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ABSTRACT: A new additive, methyl(phenyl)formamide (MPF), is introduced for the glycosylation of 2-azido-2-deoxyglucose
building blocks. A linear α-(1,4)-glucosamine tetrasaccharide was assembled to prove the utility of MPF. Next, a hexasaccharide
fragment of the Pseudomonas aeruginosa exopolysaccharide Pel was assembled using a [2 + 2 + 2] strategy modulated by MPF. The
used [galactosazide-α-(1,4)-glucosazide] disaccharide building blocks were synthesized using a 4,6-O-DTBS protected galactosyl
azide donor.
■ INTRODUCTION
Pel is one of the exopolysaccharides that is involved in the
biofilm formation of Pseudomonas aeruginosa, an opportunistic
Gram-negative pathogen that is the major cause of morbidity
and mortality in cystic fibrosis patients.1 Pel is a linear
polysaccharide composed of 1,4-linked α-N-acetyl galactos-
amine (GalNAc) and α-N-acetyl glucosamine (GlcNAc)
residues, present in a ±6:1 ratio, of which some of the
residues have been deacetylated to generate positively charged
galactosamine (GalN) and glucosamine (GlcN) moieties
(Figure 1).1b Well-defined Pel fragments can be used to
unravel their role in biofilm formation to study their
biosynthesis and possibly as synthetic antigens in the
development of a (semi)-synthetic vaccine against P.
aeruginosa. Because of the random distribution of the
monosaccharides in Pel, it is impossible to isolate well-defined
oligosaccharides from natural sources, and therefore, organic
synthesis is necessary to provide these structures.
The key challenge in the generation of these oligosacchar-
ides is the stereoselective construction of the 1,2-cis-glycosidic
linkages. Four kinds of cis-glycosidic linkages, namely α-D-
GlcN-(1 → 4)-D-GlcN, α-D-GlcN-(1 → 4)-D-GalN, α-D-GalN-
(1 → 4)-D-GlcN, and α-D-GalN-(1 → 4)-D-GalN have to be
constructed. Zhang et al. recently reported an effective
synthetic strategy to assemble galactosaminogalactans
(GAGs), fungal polysaccharides composed of 1,4-linked α-D-
Gal, α-D-GalN, and α-D-GalNAc moieties.2 For the formation
of the 1,2-cis linkages in these structures, 4,6-di-tert-
butylsilylene (4,6-O-DTBS) protected GalN donors were
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Figure 1. Repeating structures of Pel.
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used to control the selectivity.3 This strategy allowed the use of
galactosamine donors bearing differently masked amine
functionalities. Galactosazide and trichloroacetyl protected
GalN donors were used to combine GalN and GalNAc at
predetermined sites in the target GAG oligosaccharides. Of
note, the stereodirecting capacity of the DTBS group in GalN
donors effectively overrides the neighboring group participa-
tion by C2-particpating functionalities such as the trichlor-
oacetamide. Thus, DTBS-GalN donors also represent
attractive building blocks for Pel assembly. For the stereo-
selective introduction of α-D-GlcN linkages, no general
solution exists, even though the construction of this type of
glycosidic linkage has attracted significant attention,4,5 as it is
present in many important natural polysaccharides and
glycoconjugates such as heparin, heparan sulfate,6 GPI
anchors, and various bacterial polysaccharides.7
Additive controlled glycosylations are gaining increasing
interest for the stereoselective construction of glycosidic
linkages.8 In these approaches, the nature of the additive
determines the reactivity of in situ formed glycosylating species,
and the influence of the additive can be tuned to match the
reactivity of the glycosyl donor9 and acceptor10 building
blocks. We have recently reported on the fully stereoselective
assembly of a branched α-glucan with an α-(1 → 4)-linked
backbone from Mycobacterium tuberculosis, α-(1,3)-glucans
from the Aspergillus fumigatus fungal cell wall as well as the
assembly of α-(1,3)-glucans found attached to lipoteichoic
acids of Enterococcus faecalis.11 The synthetic strategy used in
these approaches hinged on the use of additive controlled
glycosylation reactions in combination with the use of a single
benzyl-type protecting group (Bn, PMB, Nap). For glyco-
sylations with relatively reactive primary alcohol acceptors, the
trimethylsilyl iodide (TMSI)-triphenylphosphine oxide
(Ph3PO) activator couple was used, while the condensations
with less reactive secondary alcohols required the use of the
trifluoromethanesulfonic acid (TfOH)-dimethylformamide
(DMF) pair. The successful construction of multiple 1,4-α-
glucosidic linkages was an incentive to explore this strategy for
the assembly of the Pel oligosaccharides. Mong and coworkers
previously described how formamide additives can be used for
the construction of 1,2-cis-GalN3 and GlcN3 linkages. They
introduced N-formyl-morpholine (NFM) to modulate the
reactivity of tri-O-benzyl GlcN3 and 4,6-benzylidene-GalN3
donors and showed that glycosylations mediated by NFM
proceeded with higher stereoselectivity than the corresponding
DMF-modulated condensations.7c Because of the stronger
electron withdrawing effect of the azide group with respect to a
benzyl ether, 2-azido donors are generally less reactive than
their 2-O-benzyl counterparts. This lower reactivity can be
counterbalanced by the use of a somewhat less nucleophilic
additive, resulting in a better leaving group Y, thereby
explaining why NFM outperforms DMF in these glycosylations
(see Scheme 1).
We here describe a strategy to synthesize Pel oligosacchar-
ides using additive-controlled glycosylations to match the
reactivities of the GlcN3 donor and the Pel acceptors. Because
of the relatively low nucleophilicity of the GlcN3-C4-OH and
especially the GalN3-C4-OH, a new additive is introduced that
generates intermediates that are more reactive than the
previously introduced DMF and NFM-imidinium ions.
■ RESULTS AND DISCUSSION
First, we paid attention to the formation of α-D-GlcN-(1 → 4)-
D-GlcN linkages. In line with previous work, solely benzyl type
protecting groups (PMB, Nap, Bn) were used (besides the
azide at C2) to generate orthogonally protected building
blocks of uniform reactivity. With donor 1 and acceptor 4 (see
SI for the syntheses of these building blocks), DMF was
investigated as an additive to control the selectivity according
to previous successful experiments. Thus, donor α-D-GlcN 1,
acceptor 4, and the additive were mixed in DCM with
molecular sieves and cooled to −78 °C. Next, TfOH was
added, and after stirring for 0.5 h, the mixture was placed at 0
°C and allowed to stir for 24 h. As shown in Table 1, this
produced the desired disaccharide product 8 with complete α-
selectivity, but the yield was only 32% (entry 1). Performing
the reaction at room temperature did not lead to erosion of
stereoselectivity but only marginally improved the yield (entry
2). Likely, the low reactivity of the donor and acceptor led to
the observed poor yield, and NFM was therefore probed as
additive.6c Use of this additive provided complete α-selectivity
and raised the yield of the condensation to 55% yield. To
further improve the reaction, a slightly less nucleophilic
additive was sought, and N-methyl-N-phenylformamide
(MPF) was explored. It was expected that the imidinium ion
formed from this additive would be more reactive because the
aniline-type nitrogen would be less capable of supporting the
(partial) positive charge in the ion (see Scheme 1). The
reaction of donor 1 and acceptor 4 proceeded with excellent
yield (91%) when performed at 0 °C, and the disaccharide 8
was obtained with 15:1 α:β-selectivity (entry 4). Although the
stereoselectivity of this condensation is somewhat less than the
DMF or NFM mediated glycosylations, the improved yield
allows for an overall more productive reaction.12
Next, our attention was turned to the formation of the α-
GlcN-(1 → 4)-GalN linkage exploring the additives as
described above. First, donor 2 was coupled with acceptor 5
using DMF to provide product 9 in low yield and poor
selectivity (Table 1, entry 5). The use of NFM instead of DMF
did not improve the outcome of this glycosylation (entry 6).
Likely, the poor reactivity of the GalN3-C4-OH hampers the
union of the two carbohydrate building blocks. Next, the use of
MPF was explored. At 0 °C, disaccharide 9 was obtained in
high yield (83%) but with moderate α:β-selectivity (5:1).
Performing the same reaction at −10 °C increased the α-
selectivity (α:β = 10:1) but led to a relatively low yield (43%,
entry 8). To increase the yield of the reaction, the
concentration was raised from 0.1 to 0.2 M (entry 9). This
led to the formation of the desired compound 9 with a yield of
88% and a 10:1 α:β ratio. Having defined adequate conditions
for the construction of α-GlcN-(1 → 4)-GlcN and α-GlcN-(1
→ 4)-GalN linkages, the use of MPF in combination with
galactosazide donor 3 was explored for the construction of the
Scheme 1. Relative Reactivity of DMF and NFM Glycosyl
Adducts
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target α-GalN-(1 → 4)-GlcN and α-GalN-(1 → 4)-GalN
linkages. Under the conditions established above, donor 3 was
coupled with glucosyl acceptor 6 to give the disaccharide 10 in
excellent yield and 8:1 α/β-stereo selectivity (entry 10).
Contrary, disaccharide 11, formed from donor 3 and galactosyl
acceptor 7, was obtained with relatively poor selectivity (α:β =
4:1, entry 11). From these model reactions, it can be
concluded that three out of four Pel-type linkages can
effectively be installed using the MPF-mediated glycosylations.
For the α-GalN-(1 → 4)-GalN linkages, the previously
reported approach using 4,6-O-DTBS galactosamine donors
is clearly superior.
Next, we probed the robustness of the MPF-mediated
protocol in the synthesis of Pel-type oligosaccharides. First, the
assembly of an all-1,2-cis linked tetraglucosamine was explored,
as depicted in Scheme 2. Thus, donor 1 and acceptor 4 were
coupled under the above identified reaction conditions to
provide the desired disaccharide 8. The PMB was removed
using a catalytic amount of HCl to give disaccharide acceptor
12 in 88% yield.13 Next, compound 12 was glycosylated with
donor 1 under the MPF conditions to form the desired
trisaccharide 13 in 83% yield and excellent stereoselectivity
(α:β > 19:1). Repetition of the deprotection and glycosylation
reactions then uneventfully provided tetrasaccharide 15. The
successful assembly of this tetrasaccharide indicates that the
yield and stereoselectivity do not decrease with the growing of
the sugar chain.
Next, the synthesis of a Pel hexasaccharide featuring both
GalN and GlcN residues was undertaken. A [2 + 2 + 2]
strategy was designed to streamline the assembly of the
structures, building on MFP-mediated glycosylations of the
GalN3-GlcN3 donor 23. The procedure for the synthesis of the
required building blocks 23 and 26 is depicted in Scheme 3A
and B. First, donor 16 was coupled with glucoazide 17 in a
chemoselective glycosylation to form disaccharide 18 as a
single anomer. Next, the silylidene ketal was cleaved with HF-
pyridine, after which a benzyl ether was regioselectively
introduced under the aegis of Taylor’s borinic acid catalyst.14
Protection of the remaining C4′-OH with a naphthyl group
delivered compound 21. Next, the anomeric thiophenol group
was removed using N-iodosuccinimide in acetone/water, and
the resulting hydroxyl group turned into the desired N-
phenyltrifluoroimidate functionality to provide donor 23.
Table 1. Glycosylation between 2-Azido Glu/Gal Donors and 4-OH-2-azido Glu/Gal Acceptors
entry donor acceptor conc (mmol/mL) additive equiv T (°C) product yield (%)a α:βb
1 1 4 0.1 DMF 16 0 8 32 >20:1
2 1 4 0.1 DMF 16 rt 8 38 >20:1
3 1 4 0.1 NFM 16 rt 8 55 >20:1
4 1 4 0.1 MPF 16 0 8 91 ∼15:1
5 2 5 0.1 DMF 16 0 8 23 6:1
6 2 5 0.1 NFM 16 0 9 24 6:1
7 2 5 0.1 MPF 16 0 9 83 5:1
8 2 5 0.1 MPF 16 −10 9 43 10:1
9 2 5 0.2 MPF 16 −10 9 88 10:1
10 3 6 0.1 MPF 16 −10 10 88 8:1
11 3 7 0.1 MPF 16 −10 11 80 4:1
aIsolated yield. bThe α:β ratio was determined by 1H NMR.
Scheme 2. Assembly of an α-Glucosazide Tetrasaccharide
Using MPF Mediated Glycosylationsa
a(a) MPF, TfOH, DCM, −78to 0 °C, 8: 91%, α:β = 15:1; 13: 83%,
α:β > 19:1; 15: 90%, α:β > 20:1. (b) 0.2 M HCl/HFIP, TES, HFIP/
DCM, 12: 88%; 14: 78%.
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Acceptor 26 was obtained from donor 16 and acceptor 4.
These two building blocks were united to stereoselectively
provide disaccharide 24. Removal of the silylidene ketal and
introduction of the C6′-O-benzyl ether as described above
provided 26. With building blocks 23 and 26 in hand, the
assembly of the target hexasaccharides was undertaken
(Scheme 3C). First, donor 23 was glycosylated with acceptor
26 using MPF as additive at −10 °C at a 0.2 M concentration
to form tetrasaccharide 27 in 89% yield as a 10:1 α/β-mixture.
Then, the Nap ether was removed using HCl and triethylsilane
in DCM/HFIP to give the tetrasaccharide acceptor 28.
Compound 28 was treated with donor 23 under the optimal
MPF-mediated glycosylation conditions to deliver hexasac-
charide 29 in high yield and stereoselectivity. Reduction of the
six azides and removal of the benzyl ester and ethers were
accomplished in a one-step reduction to give the compound
30, of which the amino groups were acetylated with acetic
anhydride to afford the Pel structure 31.
■ CONCLUSION
In conclusion, MPF is here reported for the first time as a
moderator to enable the stereoselective construction of α-
GlcN3 linkages. This additive complements previously
introduced glycosylation additives such as DMF and NFM
and expands the “nucleophilic additive toolbox” that can be
used to match the reactivity of glycosyl donor−acceptor pairs.
The applicability of the MPF-mediated glycosylations in
oligosaccharide synthesis has been demonstrated by the hand
of the assembly of Pel-type oligosaccharides. A linear
glucosazide tetrasaccharide was assembled through highly
stereoselective glycosylation reactions, using building blocks
solely equipped with benzyl type (Bn and PMB) hydroxyl
protecting groups. A [2 + 2 + 2] strategy was developed for the
assembly of a (GalN-GlcN)3 hexasaccharide in which the α-
GlcN linkages were constructed in glycosylation reactions
using MPF as an additive.
■ EXPERIMENT SECTION
General Experimental Procedures. All reagents were of
commercial grade and used as received. All moisture sensitive
reactions were performed under an argon atmosphere. DCM used in
the glycosylation reactions was dried with flamed 4 Å molecular sieves
before being used. Reactions were monitored by TLC analysis with
detection by UV (254 nm) and where applicable by spraying with
20% sulfuric acid in EtOH or with a solution of (NH4)6Mo7O24·4H2O
(25 g/L) and (NH4)4Ce(SO4)4·2H2O (10 g/L) in 10% sulfuric acid
(aq.) followed by charring at ∼150 °C. Column chromatography was
carried out using silica gel (0.040−0.063 mm). Size-exclusion
chromatography was carried out using Sephadex LH-20. 1H and 13C
spectra were recorded on a Bruker AV 400 and Bruker AV 500 in
CDCl3 or D2O. Chemical shifts (δ) are given in ppm relative to
tetramethylsilane as internal standard (1H NMR in CDCl3) or the
residual signal of the deuterated solvent. Coupling constants (J) are
given in Hz. All 13C spectra are proton decoupled. NMR peak
assignments were made using COSY and HSQC experiments; where
applicable, Clean TOCSY, HMBC and GATED experiments were
used to further elucidate the structure. The anomeric product ratios
were analyzed through integration of proton NMR signals.
Procedure A for the Glycosylation of Secondary Alcohols. A
mixture of donor (1.0 equiv), acceptor (0.7 equiv) (donors and
acceptors coevaporated with toluene three times), and MPF (16
equiv) in dry DCM was stirred over fresh flame-dried 3 Å molecular
sieves under nitrogen. The solution was cooled to −78 °C, after which
TfOH (1.0 equiv) was added. After 30 min, the reaction was stirred at
0 or −10 °C until TLC analysis showed complete conversion of the
Scheme 3. (A) Synthesis of Donor 23, (B) Synthesis of Acceptor 26, and (C) Assembly of Pel Fragment 31a
a(a) TfOH, DCM, 18: 70%; 24: 92%. (b) HF-pyridine, THF, 19: 98%, 25: 91%. (c) BnBr, borinic acid-catalyzed, K2CO3, KI, CH3CN, 60 °C, 20:
96%; 26: 95%. (d) NapBr, NaH, DMF, 21: 93%. (e) NIS, acetone, H2O. (f) 2,2,2-Trifluoro-N-phenylacetimidoyl chloride, Cs2CO3, acetone, 23:
83% over two steps. (g) MPF, TfOH, DCM, −10 °C, 48 h, 27: 89%, α:β = 10:1; 29: 91%, α:β = 10:1. (h) 0.2 M HCl/HFIP, TES, HFIP/DCM,
28: 73%. (i) H2, Pd(OH)2/C, CH3COOH, THF/H2O/t-BuOH, 30: 76%. (k) Ac2O, NaHCO3, H2O, 31: 86%.
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acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The products were purified by size exclusion
and silica gel column chromatography.
Procedure B for the Glycosylation of Primary Alcohols. A
mixture of donor (1.0 equiv), acceptor (0.7 equiv) (donors and
acceptors coevaporated with toluene three times), Ph3PO (6 equiv)
in dry DCM was stirred over fresh flame-dried 3 Å molecular sieves
under nitrogen. Then, TMSI (1.0 equiv) was added slowly into the
mixture. The reaction was stirred at room temperature until TLC
analysis indicated the reaction to be complete. The solution was
diluted, and the reaction was quenched with saturated Na2S2O3. The
organic phase was washed with water and brine, dried with anhydrous
MgSO4, filtered, and concentrated in vacuo. The products were
purified by size exclusion and silica gel column chromatography.
Procedure C for Deprotection of the PMB and Nap
Protecting Group.13 The starting material (1 equiv) was dissolved
in DCM:HFIP (1:1, 0.1 M). TES (2.0 equiv) and 0.2 M HCl/HFIP
(0.1−1 equiv) were added to the mixture. The reaction mixture was
stirred until TLC analysis indicated full consumption of the starting
material (15 min to 2 h). Then, the mixture was diluted with DCM,
and the reaction was quenched with saturated NaHCO3. The organic
phase was washed with water and brine, dried with anhydrous
MgSO4, filtered, and concentrated in vacuo. The product was purified
by silica gel column chromatography.
Experimental Procedures and Characterization Data of
Products. For the synthesis procedure and data of known
compounds 9,15a S1,15a S2,15b S3,15c and S105e, see references. We
used “a”, “b”, “c”, “d”, “e”, “f”, “g”, “h”, and “i” to specify the 1H and
13C NMR signals of sugar rings from the “reducing” to the “non-
reducing” end and “°” to specify the 1H and 13C NMR signals of the
spacer.
N-Phenyl Trifluoroacetimidate 2-N3-glucose Donor 1. Com-
pound S1 (9.1 g, 15.2 mmol) was dissolved in acetone:H2O (10:1,
150 mL). N-Iodosuccinimide (NIS) (6.9 g, 30.5 mmol) was added in
one portion, and the reaction mixture was stirred at room temperature
for 2 h. The solution was diluted with DCM, and the reaction was
quenched with saturated aqueous Na2S2O3. Then, the organic layer
was washed with water and brine. The organic layer was dried with
anhydrous MgSO4, filtered, and concentrated in vacuo, and the
product was purified by column chromatography (pentane:ethyl
acetate (EA) = 3:1). The lactol (7.2 g, 14.3 mmol) was obtained as
colorless syrup. Next, the lactol was dissolved in acetone (150 mL).
Cs2CO3 (7.0 g, 21.3 mmol) and 2,2,2-trifluoro-N-phenylacetimidoyl
chloride (3.4 mL, 21.3 mmol) were added to the solution,
respectively. The reaction was stirred overnight, then quenched
with Et3N, filtered, and concentrated in vacuo. The product was
purified by column chromatography (pentane:EA = 40:1−20:1).
Compound 1 (8.5 g, 79% over two steps, pentane:EA = 10:1, Rf =
0.45−0.55) was obtained as yellow syrup. IR (neat, cm−1) ν 697, 737,
1029, 1082, 1119, 1210, 1251, 1312, 1514, 1720, 2112 (N3), 2872,
2912. 1H NMR (CDCl3, 500 MHz, 60 °C) δ 7.38−7.20 (m, aromatic
H), 7.11−7.06 (m, aromatic H), 6.82−6.78 (m, aromatic H), 6.37 (bs,
1 H), 5.41 (bs, 1 H), 4.92−4.80 (m), 4.74−4.69 (m), 4.60−4.48 (m),
3.96 (t, J = 10.0 Hz, 1 H), 3.90 (bd, 1 H), 3.77−3.58 (m), 3.43 (t),
3.33 (bs, 1 H). 13 C-APT (CDCl3, 125 MHz, 60 °C) δ 159.8, 159.8,
143.6, 143.5, 138.3, 138.2, 138.1, 130.3 (aromatic C), 129.7, 128.9,
128.6, 128.6, 128.5, 128.1, 128.0, 1278.0, 127.9, 127.9, 127.8, 124.7,
124.6, 119.6, 114.2, 114.2 (aromatic CH), 96.2 (C-1), 94.4 (C-1),
83.3, 80.5, 77.7, 77.3, 76.4, 75.7, 75.0, 74.8, 73.9, 73.8, 73.7, 68.5,
65.8, 63.5, 55.4. HRMS (ESI) m/z: Calculated for [M − [O(C
NPh)CF3] + OH + Na]
+ C28H31O6N3Na: 582.21051, found:
582.20943.
Synthesis of N-Phenyl Trifluoroacetimidate 2-N3-glucose Donor
2. Compound S2 (8.5 g, 15 mmol) was dissolved in acetone:H2O
(10:1, 150 mL). NIS (6.7 g, 30 mmol) was added in one portion, and
the reaction mixture was stirred at room temperature for 2 h. The
solution was diluted with DCM, and the reaction was quenched with
saturated aqueous Na2S2O3. Then, the organic layer was washed with
water and brine. The organic layer was dried with anhydrous MgSO4,
filtered, and concentrated in vacuo, and the product was purified by
column chromatography (pentane:ethyl acetate (EA) = 3:1). The
lactol (6.1 g, 13 mmol) was obtained as colorless syrup. Next, the
lactol was dissolved in acetone (150 mL). Cs2CO3 (6.4 g, 19.6 mmol)
and 2,2,2-trifluoro-N-phenylacetimidoyl chloride (3.4 mL, 21.3
mmol) were added to the solution, respectively. The reaction was
stirred overnight, then quenched with Et3N, filtered, and concentrated
in vacuo. The product was purified by column chromatography
(pentane:EA = 40:1−20:1). Compound 2 (7.3 g, 87%) was obtained
as yellow syrup. IR (neat, cm−1) ν 694, 734, 1027, 1073, 1116, 1150,
1208, 1312, 1361, 1452, 1490, 1497, 1598, 1717, 2110 (N3), 2869,
3032. 1H NMR (CDCl3, 500 MHz, 60 °C) δ 7.52−6.81 (m, aromatic
H), 6.37 (bs, 1 H, H-1α), 5.43 (bs, 1 H, H-1β), 4.89−4.76 (m,
CHH), 4.60−4.48 (m, CHH), 3.98 (t, J = 9.5 Hz, 1 H), 3.91 (bd, 1
H), 3.80−3.59 (m), 3.46 (t), 3.36 (bs, 1 H). 13 C-APT (CDCl3, 125
MHz, 60 °C) δ 143.6, 143.5, 138.2, 138.2, 138.1, 138.1, 138.1
(aromatic C), 129.5, 128.9, 128.8, 128.6, 128.6, 128.5, 128.2, 128.1,
128.1, 128.0, 128.0, 127.97, 127.95, 127.91, 127.9, 126.5, 124.7, 124.6,
120.8, 119.6 (aromatic CH), 96.2 (C-1), 94.4 (C-1), 83.3, 80.5, 78.0,
77.6, 76.3, 75.7, 75.7, 75.4, 75.2, 73.9, 73.8, 73.7, 68.5, 65.8, 63.5.
HRMS (ESI) m/z: Calculated for [M − [O(CNPh)CF3] + OH +
Na]+ C27H29O5N3Na: 498.19994, found: 498.19848.
Synthesis of N-Phenyl Trifluoroacetimidate 2-N3-galactose
Donor 3. Compound S3 (3.7 g, 6.0 mmol) was dissolved in
acetone:H2O (10:1, 150 mL). NIS (2.7 g, 12 mmol) was added in one
portion, and the reaction mixture was stirred at room temperature for
2 h. The solution was diluted with DCM, and the reaction was
quenched with saturated aqueous Na2S2O3. Then, the organic layer
was washed with water and brine. The organic layer was dried with
anhydrous MgSO4, filtered, and concentrated in vacuo, and the
product was purified by column chromatography (pentane:EA = 3:1).
The lactol was obtained as colorless syrup. Next, the lactol was
dissolved in acetone. Cs2CO3 (3.0 g, 9 mmol) and 2,2,2-trifluoro-N-
phenylacetimidoyl chloride (1.5 mL, 9 mmol) were added to the
solution, respectively. The reaction was stirred overnight, then
quenched with Et3N, filtered, and concentrated in vacuo. The product
was purified by column chromatography (pentane:EA = 40:1−20:1).
Compound 3 (3.3 g, 86%) was obtained as yellow syrup. IR (neat,
cm−1) ν 695, 734, 751, 986, 1027, 1153, 1316, 1364, 1454, 1490,
1497, 1590, 1717, 2114 (N3), 2870, 2915.
1H NMR (CDCl3, 400
MHz) δ 7.56−6.79 (m, aromatic H), 6.35 (bs, 1 H, H-1), 5.49 (bs, 1
H, H-1), 5.28 (d), 4.90−4.84 (m, CHH), 4.78−4.31 (m), 4.15−3.83
(m), 3.76 (dd), 3.65−3.31 (m). 13 C-APT (CDCl3, 100 MHz) δ
143.5, 143.4, 138.5, 138.3, 138.3, 138.2, 138.1, 137.7, 137.7, 137.6,
137.6, 137.4, 137.3, 135.2 (aromatic C), 129.5, 128.8, 128.7, 128.6,
128.6, 128.6, 128.5, 128.5, 128.43, 128.37, 128.3, 128.19, 128.17,
128.15, 128.14, 128.07, 128.03, 128.00, 127.95, 127.9, 126.48, 124.46,
120.6, 119.4 (aromatic CH), 96.5 (C-1), 92.5 (C-1), 80.9, 80.7, 77.4,
75.1, 74.9, 74.8, 74.7, 74.6, 73.8, 73.67, 73.65, 73.62, 73.5, 72.9, 72.7,
72.6, 72.5, 72.4, 72.3, 72.2, 71.9, 69.7, 69.3, 68.7, 68.3, 68.1, 64.7,
62.2, 60.4, 59.2. HRMS (ESI) m/z: [M + Na]+ Calculated for
C27H29O5N3Na: 669.22953, found: 669.22913.
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Synthesis of Monosaccharide 4. The reaction was carried out
according to the standard procedure B. A mixture of donor 1 (1.0 g,
1.5 mmol), benzyl 6-hydroxyhexanoate (520 mg) (donors and
acceptors coevaporated with toluene three times), and Ph3PO (2.6
g, 9.3 mmol) in dry DCM (15 mL) was stirred over fresh flame-dried
3 Å molecular sieves under nitrogen. Then, TMSI (222 μL, 1.5
mmol) was added slowly into the mixture. The reaction was stirred at
room temperature until TLC analysis indicated the reaction to be
complete. The solution was diluted, and the reaction was quenched
with saturated Na2S2O3. The organic phase was washed with water
and brine, dried with anhydrous MgSO4, filtered, and concentrated in
vacuo. The products were purified by silica gel column chromatog-
raphy (pentane:EA = 8:1, Rf = 0.63). Compound S4 (800 mg, 75%
yield, α:β = 5:1) was obtained as a colorless syrup. IR (neat, cm−1) ν
697, 736, 1002, 1029, 1037, 1075, 1150, 1248, 1358, 1454, 1611,
1733 (CO), 2105 (N3), 2866, 2933. 1H NMR (CDCl3, 400 MHz)
δ 7.40−7.21 (m, 15 H, aromatic H), 7.00 (bd, 2 H, aromatic H), 6.79
(bd, 2 H, aromatic H), 5.09 (s, 2 H, PhCH2), 4.90 (d, J = 3.6 Hz, 1 H,
H-1a), 4.88 (s, 2 H, PhCH2),4.71 (d, J = 10.4 Hz, 1 H, CHH), 4.63
(d, J = 12.4 Hz, 1 H, CHH), 4.49 (d, J = 12.4 Hz, 1 H, CHH), 4.43
(d, J = 10.4 Hz, 1 H, CHH), 3.975 (t, t, J = 9.6 Hz, 1 H, H-3a), 3.79−
3.63 (m, 5 H, H-2a, H-4a, H-5a, H-6a, H-1°a), 3.47−3.37 (m, 1 H, H-
1°b), 3.33 (dd, 1 H, J1 = 10.0 Hz, J2 = 2.0 Hz, H-2a), 2.36 (t, J = 7.6
Hz, 2H, H-5°), 1.70−1.58 (m, 4 H, H-2°, H-4°), 1.43−1.36 (m, 2 H,
H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.4 (CO), 159.4, 138.1,
137.9, 130.1 (aromatic C), 129.6, 128.6, 128.5, 128.5, 128.2, 127.99,
127.96, 127.9, 127.8, 113.9 (aromatic CH), 97.9 (C-1a), 80.2 (C-3a),
78.0 (C-4a), 75.3, 74.8, 73.6 (CH2), 70.7 (C-5a), 68.3 (C-6a), 68.0
(C-1°), 66.1 (PhCH2), 63.4 (C-2a), 55.3 (OCH3), 34.2 (C-5°), 29.1
(C-2°), 25.7 (C-3°), 24.7 (C-4°). HRMS (ESI) m/z: [M + NH4]
+
Calculated for C41H51N4O8: 727.37014, found: 727.37015.
Then, the reaction was carried out according to the standard
procedure C. The starting material S4 (700 mg, 0.99 m mol) was
dissolved in DCM:HFIP (1:1, 0.1 M). TES (314 mL) and 0.2 M
HCl/HFIP (0.5 mL) were added to the mixture. The reaction mixture
was stirred until TLC analysis indicated full consumption of the
starting material (15 min). Then, the mixture was diluted with DCM,
and the reaction was quenched with saturated NaHCO3. The organic
phase was washed with water and brine, dried with anhydrous
MgSO4, filtered, and concentrated in vacuo. The product was purified
by silica gel column chromatography (pentane:EA = 4:1, Rf = 0.34).
Compound 4 (350 mg, 60% yield) was obtained as a colorless syrup.
[α]D
20 +59.3 (c = 1, CHCl3). IR (neat, cm
−1) ν 697, 737, 1050, 1147,
1455, 1734 (CO), 2105 (N3), 2866, 2926, 3478. 1H NMR (CDCl3,
400 MHz) δ 7.41−7.23 (m, 15 H, aromatic H), 5.10 (s, 2 H, PhCH2),
4.90 (d, J = 11.2 Hz, 1 H, CHH), 4.87 (d, J = 3.6 Hz, 1 H, H-1a), 4.81
(d, J = 11.2 Hz, 1 H, CHH), 4.59 (d, J = 12.0 Hz, 1 H, CHH), 4.53
(d, J = 12.0 Hz, 1 H, CHH), 3.86−3.64 (m, 6 H, H-2a, H-3a, H-4a,
H-5a, H-6a, H-1°a), 3.47−3.41 (m, 1 H, H-1°b), 3.25 (dd, 1 H, J1 =
10.0 Hz, J2 = 2.0 Hz, H-2a), 2.37 (t, J = 7.6 Hz, 2H, H-5°), 1.72−1.61
(m, 4 H, H-2°, H-4°), 1.47−1.37 (m, 2 H, H-3°). 13C-APT (CDCl3,
100 MHz) δ 173.6 (CO), 138.2, 137.9, 136.1 (aromatic C), 128.7,
128.6, 128.5, 128.3, 128.3, 128.1, 128.05, 127.9, 127.7, 127.5
(aromatic CH), 98.0 (C-1a), 79.8 (C-3a), 75.0 (C-6a), 73.7 (CH2),
72.2 (c-4a), 70.2 (c-5a), 69.8 (PhCH2), 68.1 (C-1°), 66.2 (PhCH2),
62.8 (C-2a), 34.2 (C-5°), 29.1 (C-2°), 25.7 (C-3°), 24.7 (C-4°).
HRMS (ESI) m/z: [M + NH4]
+ Calculated for C33H43O7N4:
607.31263, found: 607.31238.
Synthesis of Acceptor 5. Donor 16 (620 mg, 1.0 mmol) and 2-
azidoethanol (178 mg, 2.0 mmol) were dissolved in DCM and cooled
to 0 °C, and TfOH (15 μL, 0.1 mmol) was added. The reaction was
stirred at 0 °C until TLC analysis showed complete conversion of the
donor. The reaction was quenched with Et3N after completion,
checked by TLC, filtered, and concentrated in vacuo. Compound S5
(370 mg, 73%) was obtained with full α-selectivity. Then, compound
S5 was dissolved in THF. HF-pyridine was added to the solution.
After TLC analysis showed complete consumption of the starting
material, the reaction was quenched with saturated NaHCO3. The
mixture was diluted with ethyl acetate, washed with H2O and brine,
dried with anhydrous MgSO4, filtered, concentrated in vacuo. Crude
compound S6, K2CO3, KI, and borinic acid-catalyzed were mixed in
CH3CN, and then BnBr was added in the solution. The reaction was
stirred at 60 °C until TLC analysis showed complete conversion of
the starting material. The reaction was quenched with H2O after
completion, checked by TLC, filtered, and concentrated in vacuo,
purified by column chromatography (pentane:EA = 5:1). Compound
5 (280 mg, 84% yield over two steps) was obtained as colorless syrup.
[α]D
20 +89.9 (c = 1, CHCl3). IR (neat, cm
−1) ν 698, 738, 1052, 1096,
1146, 1454, 2108 (N3), 2873, 2923, 3483.
1H NMR (CDCl3, 500
MHz) δ 7.40−7.28 (m, 10 H, aromatic H), 4.95 (d, J = 3.5 Hz, 1 H,
H-1a), 4.71 (d, J = 11.5 Hz, 1 H, CHH), 4.68 (d, J = 11.5 Hz, 1 H,
CHH), 4.60 (d, J = 12.0 Hz, 1 H, CHH), 4.57 (d, J = 12.0 Hz, 1 H,
CHH), 4.12 (t, J = 1.5 Hz, 1 H, H-4a), 3.98 (t, J = 6.0 Hz, 1 H, H-5a),
3.93 (dd, 1 H, J1 = 10.5 Hz, J2 = 3.0 Hz, H-3a), 3.90−3.86 (m, 1 H,
H-1°a), 3.77−3.63 (m, 4 H, H-2a, H-6a,̲ H-1°b), 3.57−3.52 (m, 1 H,
H-2°a), 3.37−3.33 (m, 1 H, H-2°b), 2.61 (bt, 1 H, OH), 1.21−1.18
(bt, 6 H, 2 CH3).
13C-APT (CDCl3, 125 MHz) δ 137.9, 137.3
(aromatic C), 128.8, 128.6, 128.4, 128.2, 127.9, 127.8 (aromatic CH),
98.5 (C-1a), 76.0 (C-3a), 73.8, 72.1 (CH2), 69.6 (C-6a), 69.2 (C-5a),
67.2 (C-1°), 66.8 (C-4a), 59.0 (C-2a), 50.8 (C-2°). HRMS (ESI) m/
z: [M + NH4]
+ Calculated for C22H30O5N7: 472.23029, found:
472.23003.
Synthesis of Acceptor 6. Donor 1 (820 mg, 1.2 mmol),
isopropanol (200 μL, 2.6 mmol), and Ph3PO (2 g) were dissolved
in DCM (12 mL), and TMSI (173 μL) was added at room
temperature. The reaction was stirred at rt until TLC analysis showed
complete conversion of the donor. The reaction was quenched with
Et3N after completion, checked by TLC, filtered, and concentrated in
vacuo, purified by column chromatography. Compound S7 was
obtained with α:β = 5:1. Then, compound S7 was dissolved in DCM/
HFIP (1.5 mL: 1.5 mL). TES (380 μL) and 0.2 M HCl/HFIP (600
μL) were added to the mixture. The reaction mixture was stirred until
TLC analysis indicated full consumption of the starting material (30
min). Then, the mixture was diluted with DCM, and the reaction was
quenched with saturated NaHCO3. The organic phase was washed
with water and brine, dried with anhydrous MgSO4, filtered, and
concentrated in vacuo. The product was purified by silica gel column
chromatography (pentane:EA = 5:1). Compound 6 (240 mg, 47%
yield over two steps) was obtained as colorless syrup. [α]D
20 +83.4 (c
= 1, CHCl3). IR (neat, cm
−1) ν 697, 735, 1029, 1047, 1120, 1454,
2105 (N3), 2920, 2974, 3476.
1H NMR (CDCl3, 400 MHz) δ 7.40−
7.20 (m, 10 H, aromatic H), 4.97 (d, J = 3.6 Hz, 1 H, H-1a), 4.88 (d, J
= 11.2 Hz, 1 H, CHH), 4.78 (d, J = 11.2 Hz, 1 H, CHH), 4.57 (d, J =
12.0 Hz, 1 H, CHH), 4.50 (d, J = 12.0 Hz, 1 H, CHH), 3.93−3.82
(m, 3 H, H-3a, H-5a, H-1°), 3.73−3.61 (m, 3 H, H-4a, H-6a), 3.18
(dd, 1 H, J1 = 10.0 Hz, J2 = 3.6 Hz, H-2a), 2.76 (bs, 1 H, OH), 1.23,
(d, J = 8.4 Hz, 3 H, CH3), 1.21 (d, J = 8.4 Hz, 3 H, CH3).
13C-APT
(CDCl3, 100 MHz) δ 138.2, 137.8 (aromatic C), 128.5, 128.4, 128.0,
127.9, 127.7, 127.6 (aromatic CH), 96.4 (C-1a), 79.6 (C-3a), 74.9,
73.6 (CH2), 72.1 (C-4a), 70.8 (C-1°), 70.1 (C-5a), 69.7 (C-6a), 62.5
(C-2a), 23.2 (CH3), 21.5 (CH3). HRMS (ESI) m/z: [M + NH4]
+
Calculated for C23H33O5N4: 445.24455, found: 445.24441.
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Synthesis of Acceptor 7. Donor 16 (2.77 g, 4.6 mmol) and
isopropanol were dissolved in DCM (40 mL), cooled to 0 °C and
TfOH (40 μL) was added. The reaction was stirred at 0 °C until TLC
analysis showed complete conversion of the donor. The reaction was
quenched with Et3N after completion, checked by TLC, filtered, and
concentrated in vacuo. Compound S8 was obtained with full α-
selectivity. Then, compound S8 was dissolved in THF (20 mL). HF-
pyridine (1 mL) was added to the solution. After TLC analysis
showed complete consumption of the starting material, the reaction
was quenched with saturated NaHCO3. The mixture was diluted with
ethyl acetate, washed with H2O and brine, dried with anhydrous
MgSO4, filtered, concentrated in vacuo, purified by column
chromatography (pentane:EA = 3:1). Compound S9 (1.45 g) was
obtained with 94% yield over two steps. Then, compound S9 (665
mg, 1.97 mmol), K2CO3 (293 mg), KI (327 mg), and borinic acid-
catalyzed (44 mg) were mixed in CH3CN (20 mL), and then BnBr
was added in the solution. The reaction was stirred at 60 °C in oil
bath until TLC analysis showed complete conversion of the starting
material. The reaction was quenched with H2O after completion,
checked by TLC, filtered, and concentrated in vacuo, purified by
column chromatography (pentane:EA = 5:1). Compound 7 (745 mg,
80% yield) was obtained as colorless syrup. [α]D
20 +102.7 (c = 1,
CHCl3). IR (neat, cm
−1) ν 698, 737, 1052, 1454, 2108 (N3), 2892,
2926. 2972. 1H NMR (CDCl3, 400 MHz) δ 7.42−7.27 (m, 10 H,
aromatic H), 5.02 (d, J = 3.6 Hz, 1 H, H-1a), 4.71 (bs, 2 H, PhCH2),
4.58 (bs, 2 H, PhCH2), 4.15 (t, J = 1.6 Hz, 1 H, H-4a), 4.01 (bt, 1 H,
H-5a), 3.95−3.89 (m, 2 H, H-3a, H-1°), 3.76 (dd, 1 H, J1 = 10.0 Hz,
J2 = 6.0 Hz, H-6aa), 3.70−3.62 (m, 2 H, H-6ab, H-2a), 2.60 (bs, 1 H,
OH), 1.23 (d, 3 H, J = 10.4 Hz, CH3), 1.21 (d, 3 H, J = 10.4 Hz,
CH3).
13C-APT (CDCl3, 100 MHz) δ 138.0, 137.5 (aromatic C),
128.8, 128.6, 128.3, 128.1, 127.9, 127.8 (aromatic CH), 96.7 (C-1a),
76.1 (C-3a), 73.8, 72.0 (CH2), 70.9 (C-1°), 69.6 (C-6a), 68.7 (C-5a),
66.8 (C-4a), 59.0 (C-2a), 23.3 (CH3), 21.6 (CH3). HRMS (ESI) m/
z: [M + NH4]
+ Calculated for C23H33O5N4: 445.24455, found:
445.24455.
Synthesis of Disaccharide 8. The reaction was carried out
according to the standard procedure A. A mixture of donor 1 (320
mg, 0.47 mmol), acceptor 4 (185 mg, 0.31 mmol) (donors and
acceptors coevaporated with toluene three times), and MPF (610 μL)
in dry DCM (3 mL) was stirred over fresh flame-dried 3 Å molecular
sieves under nitrogen. The solution was cooled to −78 °C, after which
TfOH (42 μL) was added. After 30 min, the reaction was stirred at
−10 °C until TLC analysis showed complete conversion of the
acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 8 (304 mg, 88% yield, α:β = 15:1,
PE:EA = 4:1, Rf = 0.51) was obtained as a colorless syrup. IR (neat,
cm−1) ν 697, 736, 1027, 1147, 1249, 1358, 1454, 1514, 1734 (CO),
2103 (N3), 2866, 2928.
1H NMR (CDCl3, 400 MHz) δ 7.39−7.21
(m, 25 H, aromatic H), 7.00 (bd, 2 H, aromatic H), 6.79 (bd, 2 H,
aromatic H), 5.66 (d, J = 4.0 Hz, 1 H, H-1b), 5.11 (s, 2 H, PhCH2),
4.98(d, J = 10.4 Hz, 1 H, CHH), 4.93 (d, J = 4.0 Hz, 1 H, H-1a),
4.89−4.82 (m, 3 H, 3 CHH), 4.66 (d, J = 10.0 Hz, 1 H, CHH), 4.54−
4.47 (m, 3 H, 3 CHH), 4.37 (d, J = 10.4 Hz, 1 H, CHH), 4.23 (d, J =
10.4 Hz, 1 H, CHH), 4.07 (t, J = 9.2 Hz, 1 H, H-3a), 3.98 (t, J = 9.2
Hz, 1 H, H-4a), 3.87−3.61 (m, 10 H, H-3b, H-4b, H-5a, H-5b, H-6a,
H-6ba, OCH3), 3.54−3.44 (m, 2 H, H-6bb, H-1°a), 3.35−3.29 (m, 3
H, H-2a, H-2b, H-1°b), 2.38 (t, J = 7.6 Hz, 2H, H-5°), 1.73−1.63 (m,
4 H, H-2°, H-4°), 1.46−1.38 (m, 2 H, H-3°). 13C-APT (CDCl3, 100
MHz) δ 173.5 (CO), 159.4, 138.2, 138.0, 137.84, 137.82, 136.2,
130.2 (aromatic C), 129.7, 128.7, 128.5, 128.4, 128.2, 128.1, 128.0,
127.9, 127.84, 127.78, 127.6, 127.4, 113.9 (aromatic CH), 97.8 (C-
1b), 97.7 (C-1a), 80.9 (C-3a), 80.3 (C-3b), 77.8 (C-4b), 75.5, 74.7,
74.5, 73.6, 73.5 (PhCH2), 73.4 (c-4a), 71.6 (c-5b), 70.2 (C-5a), 69.1
(C-6a), 68.2 (C-6b), 67.9 (C-1°), 66.2 (PhCH2), 63.8 (C-2), 63.4
(C-2), 55.4 (OCH3), 34.2 (C-5°), 29.2 (C-2°), 25.8 (C-3°), 24.8 (C-
4°). HRMS (ESI) m/z: [M + NH4]
+ Calculated for C61H72N7O12:
1094.52335, found: 1094.52388.
Synthesis of Disaccharide 9. The reaction was carried out
according to the standard procedure A. A mixture of donor 2 (146
mg, 0.22 mmol), acceptor 5 (50 mg, 0.11 mmol) (donors and
acceptors coevaporated with toluene three times), and MPF (216 μL)
in dry DCM was stirred over fresh flame-dried 3 Å molecular sieves
under nitrogen. The solution was cooled to −78 °C, after which
TfOH (19 μL) was added. After 30 min, the reaction was stirred at
−10 °C until TLC analysis showed complete conversion of the
acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 9 (86 mg, 87%, α:β = 10:1) was
obtained as a colorless syrup. IR (neat, cm−1) ν 697, 736, 1027, 1046,
1093, 1127, 1150, 1259, 1359, 1454, 2105 (N3), 2869, 2923.
1H
NMR (CDCl3, 400 MHz) δ 7.40−7.05 (m, 25 H, aromatic H), 4.99
(bt, 2 H, H-1a and H-1b), 4.90−4.76 (m, 3 H, 3 CHH), 4.69 (d, J =
10.8 Hz, 1 H, CHH), 4.63 (d, J = 10.8 Hz, 1 H, CHH), 4.59−4.53
(m, 2 H, 2 CHH), 4.39 (bt, 2 H, 2 CHH), 4.31 (d, J = 2.4 Hz, 1 H),
4.13−3.49 (m, 13 H), 3.39−3.29 (m, 2 H), 3.22 (dd, J1 = 12.4 Hz, J2
= 2.0 Hz, 1 H), 2.96 (dd, J1 = 10.8 Hz, J2 = 2.0 Hz, 1 H), 4.48 (d, J1 =
10.8 Hz, J2 = 1.6 Hz, 1 H).
13C-APT (CDCl3, 100 MHz) δ 138.1,
137.8, 137.7, 137.5 (aromatic C), 128.6, 128.5, 128.4, 128.4, 128.2,
128.07, 128.06, 127.9, 127.82, 127.78, 127.75, 127.7, 127.2 (aromatic
CH), 98.9 (C-1), 98.5 (C-1), 80.2, 78.1, 75.6, 75.4, 74.9, 73.7, 73.3,
73.3, 72.0, 70.9, 69.6, 67.3, 67.3, 67.0, 64.0, 59.4, 50.7. HRMS (ESI)
m/z: [M + NH4]
+: Calculated for C49H57O9N10: 929.43045, found:
929.43039.
Synthesis of Disaccharide 10. The reaction was carried out
according to the standard procedure A. A mixture of donor 3 (77 mg,
0.12 mmol), acceptor 6 (34 mg, 0.08 mmol) (donors and acceptors
coevaporated with toluene three times), and MPF (156 μL) in dry
DCM was stirred over fresh flame-dried 3 Å molecular sieves under
nitrogen. The solution was cooled to −78 °C, after which TfOH (8
μL) was added. After 30 min, the reaction was stirred at −10 °C until
TLC analysis showed complete conversion of the acceptor. The
reaction was quenched with Et3N, filtered, and concentrated in vacuo.
The product was purified by size exclusion (DCM:MeOH = 1:1).
Compound 10 (56 mg, 88% yield, α:β = 8:1) was obtained as a
colorless syrup. IR (neat, cm−1) ν 697, 737, 1050, 1097, 1122, 1258,
1454, 2108 (N3), 2869, 2928.
1H NMR (CDCl3, 400 MHz) δ 7.41−
7.19 (m, 25 H, aromatic H), 5.64 (d, J = 3.6 Hz, 1 H, H-1a), 5.03 (d, J
= 3.6 Hz, 1 H, H-1b), 4.96 (d, J = 10.0 Hz, 1 H, CHH), 4.91 (d, J =
10.0 Hz, 1 H, CHH), 4.81 (d, J = 11.2 Hz, 1 H, CHH), 4.67 (d, J =
11.2 Hz, 1 H, CHH), 4.61 (d, J = 11.2 Hz, 1 H, CHH), 4.56 (d, J =
12.4 Hz, 1 H, CHH), 4.48 (d, J = 11.2 Hz, 1 H, CHH), 4.44 (d, J =
12.4 Hz, 1 H, CHH), 4.29 (d, J = 11.6 Hz, 1 H, CHH), 4.22 (d, J =
11.6 Hz, 1 H, CHH), 4.07 (dd, J = 8.0, 10.0 Hz, 1 H, H-3b), 3.98−
3.78 (m, 7 H), 3.72−3.63 (m, 2 H, H-6), 3.48−3.37 (m, 2 H, H-6),
3.29 (dd, J = 3.6, 10.0 Hz, 1H, H-2b), 1.28 (d, J = 6.4 Hz, 1 H, CH3),
1.24 (d, J = 6.4 Hz, 1 H, CH3).
13C-APT (CDCl3, 100 MHz) δ 138.4,
138.2, 137.9, 137.6 (aromatic C), 128.62, 128.57, 128.5, 128.42,
128.37, 128.3, 128.0, 127.92, 127.89, 127.85, 127.8, 127.5, 127.4
(aromatic CH), 98.0 (C-1a), 96.2 (C-1b), 80.8 (C-3b), 77.6 (C-3a),
74.9, 74.5 (PhCH2), 74.0 (C-2a), 73.6, 73.2 (PhCH2), 72.9 (C-4b),
72.2 (PhCH2), 71.1 (C-4a), 70.2 (C-5b), 70.1 (C-5a), 69.5 (C-6),
68.5 (C-6), 63.6 (C-2b), 59.8 (C-1°), 23.4 (CH3), 21.7 (CH3).
HRMS (ESI) m/z: [M + NH4]
+ Calculated for C50H60O9N7:
902.44470, found: 902.44467.
Synthesis of Disaccharide 11. The reaction was carried out
according to the standard procedure A. A mixture of donor 3 (77 mg,
0.12 mmol), acceptor 7 (34 mg, 0.08 mmol) (donors and acceptors
coevaporated with toluene three times), and MPF (156 μL) in dry
DCM was stirred over fresh flame-dried 3 Å molecular sieves under
nitrogen. The solution was cooled to −78 °C, after which TfOH (8
μL) was added. After 30 min, the reaction was stirred at −10 °C until
TLC analysis showed complete conversion of the acceptor. The
reaction was quenched with Et3N, filtered, and concentrated in vacuo.
The product was purified by size exclusion (DCM:MeOH = 1:1).
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Compound 11 (62 mg, 80% yield, α:β = 4:1) was obtained as a
colorless syrup. [α]D
20 +85.8 (c = 1, CHCl3). IR (neat, cm
−1) ν 697,
736, 986, 1037, 1117, 1209, 1261, 1454, 2106 (N3), 2870, 2925.
1H
NMR (CDCl3, 400 MHz) δ 7.43−7.12 (m, 25 H, aromatic H), 5.05
(d, J = 3.6 Hz, 1 H, H-1a), 4.98 (d, J = 3.6 Hz, 1 H, H-1b), 4.88 (d, J
= 12.0 Hz, 1 H, CHH), 4.80 (d, J = 10.8 Hz, 1 H, CHH), 4.72 (d, J =
11.2 Hz, 1 H, CHH), 4.63 (d, J = 11.2 Hz, 1 H, CHH), 4.54 (bd, 3
H,3 CHH), 4.47 (d, J = 10.8 Hz, 1 H, CHH), 4.36 (dd, J = 5.2, 9.2
Hz, 1 H, H-5a), 4.28 (d, J = 2.8 Hz, 1 H, H-4a), 4.10 (s, 1 H, H-4b),
4.03−3.85 (m, 8 H, H-6ba, H-5b, H-3b, H-3a, H-2b, H-2a, H-1°),
3.60 (dd, J = 3.6, 11.2 Hz, 1H, H-2a), 3.56−3.49 (m, 2 H, H-6bb, H-
6aa), 3.14−3.09 (m, 2 H, H-6ab), 1.20 (d, J = 6.0 Hz, 1 H, CH3), 1.19
(d, J = 6.0 Hz, 1 H, CH3).
13C-APT (CDCl3, 100 MHz) δ 138.7,
138.0, 137.7, 137.6 (aromatic C), 128.64, 128.58, 128.55, 128.4,
128.3, 128.2, 128.12, 128.09, 128.0, 127.90, 127.87, 127.75, 127.74,
127.6, 127.3 (aromatic CH), 98.2 (C-1b), 96.8 (C-1a), 77.4 (C-3b),
75.9 (C-3a), 75.0, 73.7, 73.2 (PhCH2), 73.0 (C-4b), 72.9 (C-4a),
71.9, 71.9 (PhCH2), 71.0 (C-1°), 69.4 (C-5b), 69.2 (C-5a), 67.7 (C-
6a), 67.2 (C-6b), 60.4 (C-2b), 59.5 (C-2a), 23.4 (CH3), 21.7 (CH3).
HRMS (ESI) m/z: [M + NH4]
+ Calculated for C50H60O9N7:
902.44470, found: 902.44482.
Synthesis of Disaccharide 12. The reaction was carried out
according to the standard procedure C. Compound 8 (200 mg, 0.18
mmol) was dissolved in DCM:HFIP (1:1, 0.1 M). TES (60 μL) and
0.2 M HCl/HFIP (100 μL) were added to the mixture. The reaction
mixture was stirred until TLC analysis indicated full consumption of
the starting material (30 min). Then, the mixture was diluted with
DCM, and the reaction was quenched with saturated NaHCO3. The
organic phase was washed with water and brine, dried with anhydrous
MgSO4, filtered, and concentrated in vacuo. The product was purified
by silica gel column chromatography (pentane:EA = 5:1, Rf = 0.22).
Compound 12 (152 mg, 88% yield) was obtained as a colorless syrup.
[α]D
20 +62.9 (c = 1, CHCl3). IR (neat, cm
−1) ν 697, 736, 1029, 1043,
1146, 1261, 1454, 1734 (CO), 2105 (N3), 2868, 2926, 3491. 1H
NMR (CDCl3, 400 MHz) δ 7.42−7.20 (m, 25 H, aromatic H), 5.64
(d, J = 3.6 Hz, 1 H, H-1b), 5.11 (s, 2 H, PhCH2), 4.98 (d, J = 10.4 Hz,
1 H, CHH), 4.93 (d, J = 3.6 Hz, 1 H, H-1a), 4.89−4.82 (m, 3 H, 3
CHH), 4.55 (d, J = 12.0 Hz, 1 H, CHH), 4.51 (d, J = 12.0 Hz, 1 H,
CHH), 4.08 (dd, J1 = 8.8 Hz, J2 = 10.0 Hz, 1 H, H-3a), 3.99 (t, J = 8.8
Hz, 1 H, H-4a), 3.86−3.65 (m, 7 H, H-3b, H-4b, H-5a, H-5b, H-6b,
H-6aa), 3.53−3.44 (m, 2 H, H-6ab, H-1°a), 3.40−3.33 (m, 2 H, H-2a,
H-1°b), 3.24 (dd, J1 = 3.6 Hz, J2 = 10.0 Hz, 1 H, H-2b), 2.68 (bs, 1 H,
OH), 2.38 (t, J = 7.6 Hz, 2H, H-5°), 1.73−1.64 (m, 4 H, H-2°, H-4°),
1.47−1.39 (m, 2 H, H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.56
(CO), 138.23, 138.17, 137.8, 137.7, 136.2 (aromatic C), 128.7,
128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.83, 127.79,
127.6, 127.4 (aromatic CH), 97.7 (C-1a), 97.6 (C-1b), 80.9 (C-3a),
79.7 (C-3b), 75.2, 74.5, 73.7, 73.4 (PhCH2), 73.1 (C-4b), 72.8 (c-4a),
70.6 (c-5b), 70.2 (C-5a), 69.9 (C-6a), 69.0 (C-6b), 68.2 (C-1°), 66.3
(PhCH2), 63.8 (C-2a), 62.8 (C-2b), 34.3 (C-5°), 29.2 (C-2°), 25.8
(C-3°), 24.8 (C-4°). HRMS (ESI) m/z: [M + NH4]
+ Calculated for
C53H64N7O11: 974.46583, found: 974.46576.
Synthesis of Trisaccharide 13. The reaction was carried out
according to the standard procedure A. A mixture of donor 1 (160
mg, 0.24 mmol), acceptor 12 (150 mg, 0.16 mmol) (donors and
acceptors coevaporated with toluene three times), and MPF (307
mL) in dry DCM (1.5 mL) was stirred over fresh flame-dried 3 Å
molecular sieves under nitrogen. The solution was cooled to −78 °C,
after which TfOH (300 μL) was added. After 30 min, the reaction was
stirred at −10 °C until TLC analysis showed complete conversion of
the acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 13 (186 mg, 81% yield, α:β >
19:1, PE:EA = 4:1, Rf = 0.40) was obtained as a colorless syrup.
[α]D
20 +75.8 (c = 1, CHCl3). IR (neat, cm
−1) ν 697, 736, 1029, 1147,
1249, 1359, 1454, 1514, 1734 (CO), 2106 (N3), 2866, 2932. 1H
NMR (CDCl3, 400 MHz) δ 7.39−7.21 (m, 35 H, aromatic H), 7.00
(bd, 2 H, aromatic H), 6.79 (bd, 2 H, aromatic H), 5.69 (d, J = 3.6
Hz, 1 H, H-1), 5.67 (d, J = 3.6 Hz, 1 H, H-1), 5.11 (s, 2 H, PhCH2),
5.02−4.82 (m, 7 H, 6 CHH, H-1a), 4.66 (d, J = 10.0 Hz, 1 H, CHH),
4.56−4.46 (m, 3 H, 3 CHH), 4.39−4.33 (m, 2 H, 2 CHH), 4.26 (d, J
= 12.0 Hz, 1 H, CHH), 4.18 (d, J = 12.0 Hz, 1 H, CHH), 4.14−3.98
(m, 4 H), 3.90−3.59 (m, 11 H), 3.56−3.44 (m, 3 H), 3.37−3.24 (m,
3 H), 2.38 (t, J = 7.6 Hz, 2H, H-5°), 1.73−1.63 (m, 4 H, H-2°, H-4°),
1.47−1.39 (m, 2 H, H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.5
(CO), 159.4, 138.3, 138.2, 138.0, 137.8, 137.7, 137.6, 136.1, 130.3
(aromatic C), 129.6, 128.6, 128.57, 128.55, 128.4, 128.3, 128.26,
128.1, 127.9, 127.86, 127.8, 127.7, 127.6, 127.5, 127.4, 127.3, 113.8
(aromatic CH), 97.8, 97.7, 97.4 (C-1a, 1b and 1c), 81.0, 80.7, 79.9
(C-3a, 3b and 3c), 77.7 (C-4c), 75.3, 74.7, 74.6, 74.2, 73.6, 73.5
(PhCH2), 73.0, 72.5 (C-4a and 4b), 71.5, 71.1, 70.2 (c-5a, 5b and 5c),
68.9, 68.7 (2 C-6), 68.2 (C-1°), 67.7 (C-6), 66.2 (PhCH2), 63.9, 63.6,
63.1 (C-2a, 2b and 2c), 55.3 (OCH3), 34.2 (C-5°), 29.1 (C-2°), 25.7
(C-3°), 24.7 (C-4°). HRMS (ESI) m/z: [M + NH4]
+ Calculated for
C81H93N10O16: 1461.67655, found: 1461.67594.
Synthesis of Trisaccharide Acceptor 14. The reaction was carried
out according to the standard procedure C. The starting material 13
(320 mg, 0.22 mmol) was dissolved in DCM:HFIP (1:1, 0.1 M). TES
(71 μL) and 0.2 M HCl/HFIP (110 μL) were added to the mixture.
The reaction mixture was stirred until TLC analysis indicated full
consumption of the starting material (15 min). Then, the mixture was
diluted with DCM, and the reaction was quenched with saturated
NaHCO3. The organic phase was washed with water and brine, dried
with anhydrous MgSO4, filtered, and concentrated in vacuo. The
product was purified by silica gel column chromatography
(pentane:EA = 4:1). Compound 14 (230 mg, 78% yield) was
obtained as a colorless syrup. [α]D
20 +51.0 (c = 3 mg/mL, CHCl3). IR
(neat, cm−1) ν 697, 737, 1028, 1148, 1454, 1736 (CO), 2106 (N3),
2866, 2926. 1H NMR (CDCl3, 400 MHz) δ 7.42−7.17 (m, 35 H,
aromatic H), 5.67−5.65 (m, 2 H, H-1b and H-1c), 5.12 (s, 2 H,
PhCH2), 5.01−4.85 (m, 7 H, 6 CHH, H-1a), 4.56 (d, J = 12.0 Hz, 1
H, CHH), 4.50 (d, J = 12.0 Hz, 1 H, CHH), 4.37−4.32 (m, 3 H, 3
CHH), 4.22 (d, J = 12.0 Hz, 1 H, CHH), 4.14−3.99 (m, 4 H), 3.87−
3.62 (m, 8 H), 3.56−3.43 (m, 3 H), 3.37−3.30 (m, 4 H), 3.18 (dd, J1
= 3.6 Hz, J2 = 10.0 Hz, 1 H, H-2c), 2.76 (bs, 1 H, OH), 2.39 (t, J =
7.6 Hz, 2H, H-5°), 1.74−1.64 (m, 4 H, H-2°, H-4°), 1.47−1.41 (m, 2
H, H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.6 (CO), 138.3,
138.20, 138.17, 137.8, 137.6, 137.5, 136.2 (aromatic C), 138.7, 128.7,
128.6, 128.55, 128.5, 128.4, 128.3, 128.13, 128.09, 128.0, 127.95,
127.9, 127.8, 127.7, 127.5, 127.48, 127.3 (aromatic CH), 97.8, 97.7,
97.4 (C-1a, 1b and 1c), 81.1, 80.8, 79.1 (C-3a, 3b and 3c), 75.0, 74.6,
74.3, 73.7, 73.5, 73.4 (PhCH2), 73.0, 72.9, 72.3 (C-4a, 4b and 4c),
71.1, 70.3, 70.2 (c-5a, 5b and 5c), 70.0, 68.9, 68.6 (C-6a, 6b and 6c),
68.3 (C-1°), 66.26 (PhCH2), 63.9, 63.7, 62.5 (C-2a, 2b and 2c), 34.3
(C-5°), 29.2 (C-2°), 25.8 (C-3°), 24.8 (C-4°). HRMS (ESI) m/z:
Calculated for C73H85N10O15: 1341.61904, found: 1341.61923.
Synthesis of Tetrasaccharide 15. The reaction was carried out
according to the standard procedure A. A mixture of donor 1 (40 mg,
0.06 mmol), acceptor 14 (35 mg, 0.03 mmol) (donors and acceptors
coevaporated with toluene three times), and MPF (52 μL) in dry
DCM (0.3 mL) was stirred over fresh flame-dried 3 Å molecular
sieves under nitrogen. The solution was cooled to −78 °C, after which
TfOH (5 μL) was added. After 30 min, the reaction was stirred at
−10 °C until TLC analysis showed complete conversion of the
acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 15 (43 mg, 87% yield, α:β > 20:1)
was obtained as a colorless syrup. [α]D
20 +94.8 (c = 1, CHCl3). IR
(neat, cm−1) ν 697, 737, 1029, 1148, 1251, 1359, 1454, 1514, 1735
(CO), 2106 (N3), 2868, 2928. 1H NMR (CDCl3, 400 MHz) δ
7.42−7.15 (m, 45 H, aromatic H), 7.00 (bd, 2 H, aromatic H), 6.79
(bd, 2 H, aromatic H), 5.70−5.67 (m, 3 H, H-1b, 1c, 1d), 5.11 (s, 2
H, PhCH2), 5.02−4.87 (m, 8 H, 7 CHH, H-1a), 4.81 (d, J = 10.4 Hz,
1 H, CHH), 4.66 (d, J = 10.4 Hz, 1 H, CHH), 4.54 (s, 2 H, PhCH2),
4.65 (d, J = 12.0 Hz, 1 H, CHH), 4.38−4.28 (m, 4 H, 4 CHH), 4.22−
4.00 (m, 8 H), 3.90−3.59 (m, 15 H), 3.52−3.44 (m, 3 H), 3.39−3.34
(m, 7 H), 2.38 (t, J = 7.6 Hz, 2H, H-5°), 1.73−1.64 (m, 4 H, H-2°, H-
4°), 1.47−1.38 (m, 2 H, H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.5
(CO), 159.4, 138.3, 138.2, 138.0, 137.84, 137.78, 137.6, 136.2,
130.3 (aromatic C), 129.7, 128.7, 128.65, 128.61, 128.59, 128.48,
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128.45, 128.4, 128.33, 128.30, 128.2, 128.02, 127.98, 127.93, 127.87,
127.8, 127.74, 127.71, 127.6, 127.5, 127.4, 127.3, 113.9 (aromatic
CH), 97.9, 97.8, 97.5, 97.48 (C-1a, 1b, 1c and 1d), 81.0, 80.9, 80.8,
80.0 (C-3a, 3b, 3c and 3d), 77.8 (C-4), 75.3, 74.7, 74.4, 74.3, 73.6,
73.6, 73.54, 73.51 (PhCH2), 73.1 (C-4), 72.4 (C-4), 72.1 (C-4), 71.5,
71.2, 71.1, 70.2 (c-5a, 5b, 5c and 5d), 68.9, 68.6, 68.3 (3 C-6), 68.29
(C-1°), 67.8 (C-6), 66.3 (PhCH2), 63.8, 63.7, 63.6, 63.2 (C-2a, 2b, 2c
and 2d), 55.4 (OCH3), 34.3 (C-5°), 29.2 (C-2°), 25.8 (C-3°), 24.8
(C-4°).
Synthesis of N-Phenyl Trifluoroacetimidate 2-N3-galactose
Donor 16. NIS (9.15 g, 40.68 mmol) was added to the solution of
compound S3 (18 g, 31.3 mmol) in Acetone/H2O (210 mL/72 mL)
at 0 °C. The reaction was slowly warmed to room temperature and
stirred until TLC analysis indicated full consumption of the starting
material (±1h). Then, the mixture was diluted with DCM and washed
with saturated Na2S2O3 and brine, dried with anhydrous MgSO4,
filtered, and concentrated in vacuo. The lactol was purified by silica gel
column chromatography (pentane:EA = 4:1). Cs2CO3 was added to
the solution of The lactol (10.59g, 24.33 mmol) in 140 mL acetone.
The mixture was stirred at 0 °C for 15 min. Then, CF3C(NPh)Cl
(6.06 g, 29.2 mmol) was added to the solution. which was slowly
warmed to room temperature and stirred overnight. The reaction was
quenched with Et3N and concentrated in vacuo. The product 16 was
purified by silica gel column chromatography (pentane:Et2O = 30:1−
10:1). Compound 16 (13.3 g, a/b = 2:1, 90% yield, PE: Et2O = 10:1,
Rf = 0.45−0.55) was obtained as white solid. α isomer: 1H NMR
(CDCl3, 400 MHz) δ 7.50−7.24 (m, 7H, aromatic H), 7.15−7.05 (m,
1H, aromatic H), 6.84 (d, J = 7.7 Hz, 2H, aromatic H), 6.47 (bs, 1H,
H-1), 4.78 (d, J = 11.4 Hz, 1H, CH2Ph), 4.69 (d, J = 11.4 Hz, 1H,
CH2Ph), 4.63 (s, 1H, H-4), 4.22 (q, J = 12.8 Hz, 2H. H-6), 4.10 (t, J =
6.3 Hz, 1H, H-2), 3.89 (d, J = 9.5 Hz, 1H, H-3), 3.76 (s, 1H, H-5),
1.09−1.02 (m, 18H, CH3). 13C NMR (100 MHz, CDCl3) δ 143.29,
137.45, 128.74, 128.56, 128.01, 127.91, 124.40, 119.35 (aromatic C/
CH), 94.73 (C-1), 76.04 (C-3), 70.71 (CH2Ph), 69.89 (C-5), 69.16
(C-4), 66.76 (C-6), 57.71 (C-2), 27.59 (CH3), 27.23 (CH3), 23.38
(C-Si), 20.73 (C-Si). β isomer: 1H NMR (CDCl3, 400 MHz) δ 7.48−
7.25 (m, 7H, aromatic H), 7.14−7.04 (m, 1H, aromatic H), 6.85 (d, J
= 7.7 Hz, 2H, aromatic H), 5.50 (bs, 1H, H-1), 4.77 (d, J = 11.9 Hz,
1H, CH2Ph), 4.66 (d, J = 11.9 Hz, 1H, CH2Ph), 4.43 (s, 1H, H-5),
4.19 (s, 2H, H-6), 4.02 (s, 1H, H-4), 3.30 (s, 2H, H-2, 3), 1.15−1.00
(m, 18H, CH3).
13C NMR (100 MHz, CDCl3) δ 143.5, 137.5, 128.8,
128.7, 128.2, 128.0, 124.5, 119.4 (aromatic C/CH), 95.8 (C-1), 79.6
(C-3), 72.2 (C-2), 71.0 (CH2Ph), 68.6 (C-5), 66.8 (C-6), 60.8 (C-4),
27.7 (CH3), 27.4 (CH3), 23.6 (C-Si), 20.9 (C-Si). HRMS (ESI) m/z:
[M + NH4]
+ Calculated for C21H37N3O5Si: 629.2383, found:
629.2376.
Synthesis of Disaccharide 18. Donor 16 (5 g, 8.2 mmol) and
acceptor 17 (3.32 g, 6.95 mmol) (donors and acceptors coevaporated
with toluene three times) were dissolved in DCM (65 mL) and
cooled to 0 °C, and TfOH (60 μL) was added. The reaction was
stirred at 0 °C until TLC analysis showed complete conversion of the
donor. The reaction was quenched with Et3N after completion,
checked by TLC, filtered, and concentrated in vacuo. The product 16
was purified by silica gel column chromatography (pentane:Et2O =
10:1). Compound 18 (4.36g, 70% yield) was obtained with full α-
selectivity as a colorless syrup. [α]D
20 +153.3 (c = 1, CHCl3). IR
(neat, cm−1) ν 651, 698, 738, 797, 826, 984, 1043, 1066, 1100, 1171,
1364, 1473, 2107 (N3), 2859, 2933.
1H NMR (CDCl3, 400 MHz) δ
7.53−7.51 (m, 2 H, aromatic H), 7.44−7.22 (m, 18 H, aromatic H),
5.64 (d, J = 3.6 Hz, 1 H, H-1b), 5.59 (d, J = 5.2 Hz, 1 H, H-1a), 5.00
(d, J = 10.4 Hz, 1 H, CHH), 4.91 (d, J = 10.4 Hz, 1 H, CHH), 4.73
(d, J = 11.6 Hz, 1 H, CHH), 4.63 (d, J = 11.6 Hz, 1 H, CHH), 4.43−
4.37 (m, 4 H, 2 CHH, H-4b, H-5a), 3.96−3.77 (m, 6 H, H-2a, H-2b,
H-3a, H-4a, H-6), 3.72−3.64 (m, 2 H, H-3b, H-6a), 3.53 (dd, J1 = 2.0
Hz, J2 = 10.8 Hz, 1 H, H-6b), 3.42 (s, 1 H, H-5b), 1.03 (s, 9 H, 3
CH3), 0.97 (s, 9 H, 3 CH3).
13C-APT (CDCl3, 100 MHz) δ 137.9,
137.8, 137.4, 133.5 (aromatic C), 132.1, 129.2, 128.62, 128.58,
128.51, 128.48, 128.00. 127.98, 127.8, 127.5 (aromatic CH), 97.7 (C-
1b), 87.1 (C-1a), 82.3 (C-3a), 75.5 (C-3b), 75.0, 73.3 (PhCH2), 72.8
(c-4a), 71.3 (c-5a), 70.5 (PhCH2), 69.6 (C-4b), 68.9 (C-6), 68.0 (C-
5b), 66.9 (C-6), 64.6 (C-2a), 58.1 (C-2b), 27.7 (3 CH3), 27.3 (3
CH3), 23.4, 20.7. HRMS (ESI) m/z: [M + NH4]
+ Calculated for
C47H62N7O8SSi: 912.41444, found: 912.41409.
Synthesis of Disaccharide 20. Compound 18 (4.1 g, 4.6 mmol)
was dissoveld in THF (40 mL) in a round flusk. Then, HF-pyridine
(1.2 mL) was added in the solution. The reaction mixture was stirred
until TLC analysis indicated full consumption of the starting material
(30 min). Then, the mixture was diluted with DCM, and the reaction
was quenched with saturated NaHCO3. The organic phase was
washed with water and brine, dried with anhydrous MgSO4, filtered,
and concentrated in vacuo. The crude compound 19 was dissolved in
CH3CN (47 mL). Then, BnBr (880 μL), borinic acid-catalyzed (110
mg), K2CO3 (710 mg), KI (800 mg) were added into the mixture.
The reaction mixture was stirred at 60 °C in oil bath until TLC
analysis indicated full consumption of the starting material (24 h).
Then, the mixture was diluted with ethyl acetate and the reaction
quenched with saturated NaHCO3. The organic phase was washed
with water and brine, dried with anhydrous MgSO4, filtered, and
concentrated in vacuo. The product was purified by silica gel column
chromatography (pentane:Et2O = 5:1). Compound 20 (3.6 g, 94%
yield with two steps) was obtained as a colorless syrup. [α]D
20 +11.7
(c = 1, CHCl3). IR (neat, cm
−1) ν 697, 737, 1029, 1046, 1077, 1266,
2106 (N3), 2870, 2919, 3493.
1H NMR (CDCl3, 400 MHz) δ 7.54−
7.51 (m, 2 H, aromatic H), 7.41−7.23 (m, 23 H, aromatic H), 5.61
(d, J = 3.6 Hz, 1 H, H-1b), 5.60 (d, J = 5.2 Hz, 1 H, H-1a), 5.00 (d, J
= 10.4 Hz, 1 H, CHH), 4.94 (d, J = 10.4 Hz, 1 H, CHH), 4.66 (s, 2 H,
PhCH2), 4.50−4.37 (m, 3 H, 2 CHH, 5a), 4.08 (s, 1 H, H-4b), 3.97−
3.91 (m, 2 H, H-2b, H-4a), 3.85−3.37 (m, 5 H), 3.66 (dd, J1 = 2.4
Hz, J2 = 10.8 Hz, 1 H, H-6b), 3.59 (dd, J1 = 5.6 Hz, J2 = 9.6 Hz, 1 H),
3.51 (dd, J1 = 5.6 Hz, J2 = 9.6 Hz, 1 H), 2.63 (s, 1 H, OH).
13C-APT
(CDCl3, 100 MHz) δ 138.3, 137.8, 137.6, 137.2, 133.5 (aromatic C),
132.3, 128.8, 128.6, 128.5, 128.4, 128.3, 128.1, 128.o, 127.9, 127.86,
127.85, 127.6, 127.55 (aromatic CH), 98.2 (C-1b), 87.1 (C-1a), 82.1
(C-3a), 76.3 (C-3b), 75.1 (PhCH2), 74.4 (c-4a), 73.8, 73.2, 71.8
(PhCH2), 71.3 (c-5a), 69.5 (C-6), 69.4 (C-6), 69.3 (C-5b), 66.5 (C-
4b), 64.8 (C-2b), 59.0 (C-2a). HRMS (ESI) m/z: [M + NH4]
+
Calculated for C46H52N7O8S: 862.35926, found: 862.35895.
Synthesis of Thio-disaccharide 21. The compound 20 (3.83 g,
4.53 mmol) was dissolved in DMF (10 mL). Then, NaH (544 mg)
and NapBr (1.5 g) were added into the mixture. The reaction mixture
was stirred until TLC analysis indicated full consumption of the
starting material (2 h). Then, the mixture was diluted with ethyl
acetate and the reaction quenched with ice water. The organic phase
was washed with water and brine, dried with anhydrous MgSO4,
filtered, and concentrated in vacuo. The product was purified by silica
gel column chromatography (pentane:Et2O = 10:1). Compound 21
(4.15 g, 93% yield) was obtained as a colorless syrup. [α]D
20 +208.6
(c = 1, CHCl3). IR (neat, cm
−1) ν 697, 737, 1028, 1049, 1093, 1123,
1362, 1454, 2106 (N3), 2870. 2914.
1H NMR (CDCl3, 400 MHz) δ
7.80−7.11 (m, 32 H, aromatic H), 5.64 (d, J = 3.6 Hz, 1 H, H-1b),
5.59 (d, J = 5.2 Hz, 1 H, H-1a), 5.01−4.89 (m, 3 H, 3 CHH), 4.70−
4.62 (m, 3 H, 3 CHH), 4.50 (d, J = 12.0 Hz, 1 H, CHH), 4.44−4.40
(m, 2 H, CHH, 5b), 4.27 (d, J = 11.6 Hz, 1 H, CHH), 4.17 (d, J =
11.6 Hz, 1 H, CHH), 4.04 (s, 1 H, H-4b), 3.97−3.81 (m, 6 H, H-2a,
H-2b, H-3a, H-3b, H-4a, H-5a), 3.77−3.65 (m, 2 H, H-6), 3.51−3.40
(m, 2 H, H-6). 13C-APT (CDCl3, 100 MHz) δ 138.3, 137.8, 137.60,
137.58, 135.6, 133.6, 133.2, 133.1 (aromatic C), 133.08, 129.2, 128.7,
128.6, 128.5, 128.4, 128.3, 128.1, 127.99, 127.97, 127.93, 127.80,
127.6, 127.4, 127.2, 126.5, 126.2, 126.1 (aromatic CH), 98.3 (C-1b),
87.1 (C-1a), 82.2 (C-3a), 77.5 (C-3b), 75.2, 74.9 (PhCH2), 74.1 (c-
4a), 73.6, 73.1 (PhCH2), 72.8 (C-4b), 72.3 (PhCH2), 71.3 (C-5b),
70.4 (C-5a), 69.4 (C-6), 68.6 (C-6), 64.8 (C-2a), 69.8 (C-2b).
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HRMS (ESI) m/z: [M + NH4]
+ Calculated for C57H60N7O8S:
1002.42186, found: 1002.42125.
N-Phenyl Trifluoroacetimidate Disaccharide Donor 23. Com-
pound 21 (4.15 g, 4.21 mmol) was dissolved in acetone:H2O (10:1,
44 mL). NIS (2.0 g, 8.8 mmol) was added in one portion, and the
reaction mixture was stirred at room temperature for 2 h. The
solution was diluted with DCM, and the reaction was quenched with
saturated aqueous Na2S2O3. Then, the organic layer was washed with
water and brine. The organic layer was dried with anhydrous MgSO4,
filtered, and concentrated in vacuo, and the product was purified by
column chromatography (pentane:EA = 3:1). The lactol 22 was
obtained as colorless syrup. Next, the lactol was dissolved in acetone
(40 mL). Cs2CO3 (1.9 g) and 2,2,2-trifluoro-N-phenylacetimidoyl
chloride (960 μL) were added to the solution, respectively. The
reaction was stirred overnight, then quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by column
chromatography (pentane:EA = 40:1−20:1). Compound 23 (3.7 g,
81% over two steps) was obtained as yellow syrup. IR (neat, cm−1) ν
695, 734, 818, 1027, 1116, 1209, 1312, 1454, 1489, 1497, 1717, 2107,
2870, 2918. 1H NMR (CDCl3, 500 MHz) δ 7.80−7.09 (m, aromatic
H), 6.81 (bt, 1 H), 5.65 (dd, 1 H), 5.01−4.87 (m), 4.68−4.54 (m),
4.45−4.42 (m), 4.33−4.18 (m), 4.03−3.41 (m). 13 C-APT (CDCl3,
125 MHz) δ 143.4, 143.2, 138.20, 138.18, 137.8, 137.6, 137.55, 137.5,
135.6, 133.3, 133.2 (aromatic C), 128.9, 128.7, 128.53, 128.52,
128.44, 128.43, 128.3, 128.08, 128.05, 128.0, 127.97, 127.9, 127.84,
127.81, 127.69, 127.66, 127.65, 127.6, 127.2, 127.17, 124.7, 124.6
(aromatic CH), 119.4 (C-1), 98.3 (C-1), 98.2 (C-1), 83.6, 81.0, 77.6,
77.3, 75.5, 75.18, 75.16, 75.0, 74.9, 73.64, 73.60, 73.30, 73.2, 73.1,
73.0, 72.8, 72.7, 72.3, 72.2, 70.4, 70.3, 69.0, 68.5, 65.8, 63.7, 59.7,
59.6. HRMS (ESI) m/z: [M − [O(CNPh)CF3] + OH + Na]+
Calculated for C59H56F3N7O9Na: 910.41340, found: 910.41374.
Synthesis of Disaccharide 24. Donor 16 (1.09 g) and acceptor 4
(790 mg) (donors and acceptors coevaporated with toluene three
times) were dissolved in DCM (12 mL) and cooled to 0 °C, and
TfOH (12 μL) was added. The reaction was stirred at 0 °C until TLC
analysis showed complete conversion of the donor. The reaction was
quenched with Et3N after completion, checked by TLC, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 24 (1.24 g, 92% yield) was
obtained with full α-selectivity as a colorless syrup. [α]D
20 +95.9 (c =
1, CHCl3). IR (neat, cm
−1) ν 651, 698, 737, 765, 797, 826, 984, 1004,
1040, 1130, 1144, 1171, 1455, 1474, 1735 (CO), 2106 (N3), 2860,
2933. 1H NMR (CDCl3, 400 MHz) δ 7.44−7.24 (m, 20 H, aromatic
H), 5.67 (d, J = 3.6 Hz, 1 H, H-1b), 5.12 (s, 2 H, PhCH2), 4.96 (d, J =
10.4 Hz, 1 H, CHH), 4.92 (d, J = 3.6 Hz, 1 H, H-1a), 4.86 (d, J = 10.4
Hz, 1 H, CHH), 4.71 (d, J = 11.6 Hz, 1 H, CHH), 4.61 (d, J = 11.6
Hz, 1 H, CHH), 4.48 (s, 2 H, PhCH2), 4.36 (d, J = 2.0 Hz, 1 H, H-
4b), 4.06 (dd, J1 = 10 Hz, J2 = 8.4 Hz, 1 H, H-3a), 3.91−3.78 (m, 4
H), 3.74−3.45 (m, 6 H), 3.34−3.30 (m, 2 H, H-2a, H-1°b), 2.39 (t, J
= 7.6 Hz, 2H, H-5°), 1.74−1.64 (m, 4 H, H-2°, H-4°), 1.48−1.42 (m,
2 H, H-3°), 1.03 (s, 9 H, 3 CH3), 0.95 (s, 9 H, 3 CH3). 13C-APT
(CDCl3, 100 MHz) δ 173.5 (CO), 138.0, 137.9, 137.7, 136.2
(aromatic C), 128.7, 128.6, 128.3, 128.0, 127.96, 127.9, 127.86, 127.6
(aromatic CH), 97.9 (C-1b), 97.5 (C-1a), 81.0 (C-3a), 75.5 (C-3b),
74.3, 73.5 (PhCH2), 72.4 (c-4a), 70.5 (PhCH2), 70.1 (c-5a), 69.6 (C-
4b), 69.1 (C-6), 68.3 (C-1°), 67.9 (C-5b), 66.9 (C-6), 66.3 (PhCH2),
63.6 (C-2a), 58.1 (C-2b), 34.3 (C-5°), 29.2 (C-2°), 27.7 (3 CH3),
27.3 (3 CH3), 25.8 (C-3°), 24.8 (C-4°), 23.4, 20.7. HRMS (ESI) m/
z: [M + NH4]
+ Calculated for C54H74N7O11Si: 1024.52101, found:
1024.52157.
Synthesis of Disaccharide 25. Compound 24 (1.16 g, 1.15 mmol)
was dissoveld in THF (11 mL) in a round flusk. Then, HF-pyridine
(300 μL) was added in the solution. The reaction mixture was stirred
until TLC analysis indicated full consumption of the starting material
(30 min). Then, the mixture was diluted with DCM, and the reaction
was quenched with saturated NaHCO3. The organic phase was
washed with water and brine, dried with anhydrous MgSO4, filtered,
and concentrated in vacuo. The product was purified by silica gel
column chromatography (pentane:Et2O = 3:1). Compound 25 (910
mg, 91% yield) was obtained as a colorless syrup. [α]D
20 +80.6 (c = 1,
CHCl3). IR (neat, cm
−1) ν 698, 738, 1040, 1145, 1262, 1354, 1455,
1733 (CO), 2106 (N3), 2872, 2932, 3461. 1H NMR (CDCl3, 400
MHz) δ 7.38−7.25 (m, 20 H, aromatic H), 5.65 (d, J = 3.6 Hz, 1 H,
H-1b), 5.12 (s, 1 H, PhCH2), 4.97 (d, J = 10.4 Hz, 1 H, CHH), 4.92
(d, J = 3.6 Hz, 1 H, H-1a), 4.88 (d, J = 10.4 Hz, 1 H, CHH), 4.67−
4.54 (m, 4 H, 4 CHH), 4.05 (dd, J1 = 10.0 Hz, J2 = 8.4 Hz, 1 H, H-
3a), 3.91−3.80 (m, 2 H, H-4a, H-5), 3.74−3.57 (m, 8 H), 3.51−3.44
(m, 1 H, H-1°b), 3.31 (dd, J1 = 10.0 Hz, J2 = 3.6 Hz, 1 H, H-2a), 2.65
(s, 1 H, OH), 2.39 (t, J = 7.6 Hz, 2H, H-5°), 2.29 (s, 1 H, OH),
1.74−1.64 (m, 4 H, H-2°, H-4°), 1.47−1.40 (m, 2 H, H-3°). 13C-APT
(CDCl3, 100 MHz) δ 173.60 (CO), 138.1, 137.80, 137.1, 136.1
(aromatic C), 128.8, 128.7, 128.6, 128.5, 128.4, 128.31, 128.29, 128.1,
127.9, 127.8, 127.7 (aromatic CH), 97.9 (C-1b), 97.7 (C-1a), 80.8
(C-3a), 76.1 (C-3b), 74.5 (PhCH2), 73.8 (c-4a), 73.7 (PhCH2), 71.9
(PhCH2), 70.3 (c-5b), 70.2 (C-5a), 69.7 (C-6), 68.3 (C-1°), 67.2 (C-
4b), 66.3 (PhCH2), 63.8 (C-2a), 62.9 (C-6), 58.8 (C-2b), 34.3 (C-
5°), 29.2 (C-2°), 25.8 (C-3°), 24.8 (C-4°). HRMS (ESI) m/z: [M +
NH4]
+ Calculated for C46H60N7O11: 884.41888, found: 884.41942.
Synthesis of Disaccharide Acceptor 26. The compound 25 (865
mg, 1.0 mmol) was dissolved in CH3CN (10 mL). Then, BnBr (182
μL), borinic acid catalyst (22 mg), K2CO3 (148 mg), and KI (166
mg) were added into the mixture. The reaction mixture was stirred at
60 °C in oil bath until TLC analysis indicated full consumption of the
starting material (24 h). Then, the mixture was diluted with ethyl
acetate, and the reaction was quenched with saturated NaHCO3. The
organic phase was washed with water and brine, dried with anhydrous
MgSO4, filtered, and concentrated in vacuo. The product was purified
by silica gel column chromatography (pentane:Et2O = 5:1).
Compound 26 (910 mg, 95%) was obtained as a colorless syrup.
[α]D
20 +66.6 (c = 1, CHCl3). IR (neat, cm
−1) ν 697, 736, 1040, 1096,
1259, 1455, 1734 (CO), 2106 (N3), 2869, 2928. 1H NMR (CDCl3,
400 MHz) δ 7.40−7.21 (m, 25 H, aromatic H), 5.64 (d, J = 3.6 Hz, 1
H, H-1b), 5.11 (s, 1 H, PhCH2), 4.96 (d, J = 10.4 Hz, 1 H, CHH),
4.91 (d, J = 3.6 Hz, 1 H, H-1a), 4.88 (d, J = 10.4 Hz, 1 H, CHH), 4.63
(bs, 2 H, 2 CHH), 4.55 (d, J = 12.0 Hz, 1 H, CHH), 4.45 (d, J = 12.0
Hz, 1 H, CHH), 4.47−4.36 (m, 3 H, 3 CHH), 4.07−4.03 (m, 2 H, H-
3a, H-5a), 3.91−3.44 (m, 12 H), 3.32 (dd, J1 = 11.2 Hz, J2 = 3.6 Hz, 1
H, H-2a), 2.65 (s, 1 H, OH), 2.38 (t, J = 7.6 Hz, 2H, H-5°), 1.73−
1.63 (m, 4 H, H-2°, H-4°), 1.47−1.39 (m, 2 H, H-3°). 13C-APT
(CDCl3, 100 MHz) δ 173.5 (CO), 138.3, 137.8, 137.3, 136.1
(aromatic C), 129.1, 128.7, 128.65, 128.54, 128.50, 128.4, 128.3,
128.0, 127.9, 127.8, 127.6, 127.6, 127.3 (aromatic CH), 97.9 (C-1b),
97.7 (C-1a), 80.8 (C-3a), 76.3 (C-3b), 74.5 (PhCH2), 73.9 (C-4a),
73.8, 73.3, 71.7 (PhCH2), 70.1 (C-4b), 69.5, 69.4 (C-6), 69.2 (C-5b),
68.2 (C-1°), 66.4 (C-5a), 66.2 (PhCH2), 63.7 (C-2a), 58.9 (C-2b),
34.2 (C-5°), 29.1 (C-2°), 25.7 (C-3°), 24.8 (C-4°). HRMS (ESI) m/
z: [M + NH4]
+ Calculated for C53H64N7O11: 974.46583, found:
974.46660.
Synthesis of Tetrasaccharide 27. The reaction was carried out
according to the standard procedure A. A mixture of donor 23 (520
mg, 0.49 mmol), acceptor 26 (238 mg, 0.25 mmol) (donors and
acceptors coevaporated with toluene three times), and MPF (490 μL)
in dry DCM (1 mL) was stirred over fresh flame-dried 3 Å molecular
sieves under nitrogen. The solution was cooled to −78 °C, after which
TfOH (40 μL) was added. After 30 min, the reaction was stirred at
−10 °C until TLC analysis showed complete conversion of the
acceptor. The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 27 (280 mg, 89%, α:β = 10:1) was
obtained as a colorless syrup. IR (neat, cm−1) ν 697, 736, 1028, 1096,
1258, 1319, 1356, 1454, 1497, 1731 (CO), 2105 (N3), 2868, 2925.
1H NMR (CDCl3, 400 MHz) δ 7.77−7.69 (m, 3 H, aromatic H), 7.60
(bs, 1 H, aromatic H), 7.42−7.17 (m, 48 H, aromatic H), 5.73 (d, J =
3.6 Hz, 1 H, H-1d), 5.65 (d, J = 3.6 Hz, 1 H, H-1b), 5.10 (s, 1 H,
PhCH2), 4.96−4.90 (m, 7 H), 4.74−4.48 (m, 7 H), 4.36−3.61 (m, 22
H), 3.51−3.26 (m, 6 H), 3.20 (d, J = 10.0 Hz, 1 H), 3.03 (d, J = 10.0
Hz, 1 H), 2.36 (t, J = 7.6 Hz, 2H, H-5°), 1.71−1.61 (m, 4 H, H-2°, H-
4°), 1.45−1.37 (m, 2 H, H-3°). 13C-APT (CDCl3, 100 MHz) δ 173.4
(CO), 138.4, 138.2, 137.7, 137.68, 137.6, 137.54, 137.47, 136.1,
135.6, 133.1, 133.0 (aromatic C), 128.6, 128.5, 128.4, 128.38, 128.35,
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128.27, 128.25, 128.2, 128.1, 128.07, 128.0, 127.9, 127.88, 127.86,
127.78, 127.76, 127.66, 127.6, 127.4, 127.3, 127.1, 127.0, 126.4, 126.0,
125.9 (aromatic CH), 98.7 (C-1), 98.1 (C-1), 97.8 (C-1), 97.7 (C-1),
81.0 (C-3), 80.7 (C-3), 76.8 (C-3), 75.1 (C-3), 74.9, 74.5, 74.4
(CH2), 73.5 (C-4), 73.5, 73.3 (CH2), 73.2 (C-4), 72.9 (C-4), 72.8
(C-4), 72.8, 72.2, 71.7 (CH2), 70.6 (C-5), 70.1 (C-5), 69.9 (C-5),
69.8 (C-5), 69.2, 68.4, 68.1, 67.9, 66.8, 66.1 (CH2), 64.7 (C-2), 63.7
(C-2), 59.5 (C-2), 59.4 (C-2), 34.1 (C-5°), 29.0 (C-2°), 25.6 (C-3°),
24.7 (C-4°). HRMS (ESI) m/z: [M + NH4]+ Calculated for
C104H114N13O19: 1848.83484, found: 1848.83541.
Synthesis of Tetrasaccharide Acceptor 28. The reaction was
carried out according to the standard procedure C. Compound 27
(700 mg, 0.38 mmol) was dissolved in DCM:HFIP (1:1, 0.1 M). TES
(304 μL, 1.91 mmol) and 0.2 M HCl/HFIP (1.9 mL) were added to
the mixture. The reaction mixture was stirred until TLC analysis
indicated full consumption of the starting material (15 min). Then,
the mixture was diluted with DCM, and the reaction was quenched
with saturated NaHCO3. The organic phase was washed with water
and brine, dried with anhydrous MgSO4, filtered, and concentrated in
vacuo. The product was purified by silica gel column chromatography
(pentane:Et2O = 5:1). Compound 28 (297 mg, 73% yield) was
obtained as a colorless syrup. [α]D
20 +106.7 (c = 1, CHCl3). IR (neat,
cm−1) ν 696, 737, 1040, 1100, 1261, 1454, 1735 (CO), 2106 (N3),
2869, 2926. 1H NMR (CDCl3, 500 MHz) δ 7.42−7.17 (m, 45 H,
aromatic H), 5.71 (d, J = 3.5 Hz, 1 H, H-1d), 5.65 (d, J = 3.5 Hz, 1 H,
H-1b), 5.10 (s, 1 H, PhCH2), 4.95−4.89 (m, 6 H, H-1a, H-1c, 4
CHH), 4.72 (d, J = 12.0 Hz, 1 H, CHH), 4.68 (s, 2 H, 2 CHH),
4.57−4.48 (m, 3 H), 4.36−4.17 (m, 7 H), 4.09−3.58 (m, 17 H),
3.51−3.30 (m, 3 H), 3.36−3.30 (m, 3 H), 3.91−3.44 (m, 12 H), 3.17
(dd, J1 = 11.5 Hz, J2 = 2.5 Hz, 1 H), 3.02 (dd, J1 = 11.5 Hz, J2 = 2.5
Hz, 1 H), 2.66 (s, 1 H, OH), 2.37 (t, J = 7.5 Hz, 2H, H-5°), 1.71−
1.63 (m, 4 H, H-2°, H-4°), 1.45−1.39 (m, 2 H, H-3°). 13C-APT
(CDCl3, 125 MHz) δ 173.5 (CO), 138.5, 138.3, 137.8, 137.7,
137.68, 137.6, 137.4, 136.2 (aromatic C), 128.8, 128.7, 128.6, 128.6,
128.5, 128.3, 128.2, 128.18, 128.0, 127.9, 127.9, 127.86, 127.8, 127.7,
127.69, 127.5, 127.5, 127.3, 127.2 (aromatic CH), 98.8 (C-1), 98.1
(C-1), 97.9 (C-1), 97.8 (C-1), 80.9 (C-3), 80.8 (C-3), 76.1 (C-3),
75.8 (C-3), 74.54, 74.46, 73.7 (CH2), 73.6 (C-4), 73.56, 73.4 (CH2),
73.1 (2 C-4), 73.07 71.8, 71.75 (CH2), 70.7 (C-4), 70.2 (C-5), 69.9
(C-5), 69.3, 69.1 (CH2), 68.8 (C-5), 68.5, 68.3, 68.9 (CH2), 66.5 (C-
5), 66.3 (PhCH2), 64.7 (C-2), 63.8 (C-2), 59.6 (C-2), 58.8 (C-2),
34.3 (C-5°), 29.2 (C-2°), 25.8 (C-3°), 24.8 (C-4°). HRMS (ESI) m/
z: [M + NH4]
+ Calculated for C93H106N13O19: 1708.77224, found:
1708.77299.
Synthesis of Hexasaccharide 29. The reaction was carried out
according to the standard procedure A. A mixture of donor 23 (540
mg, 0.5 mmol), acceptor 28 (360 mg, 0.21 mmol) (donors and
acceptors coevaporated with toluene three times), and MPF (400 μL)
in dry DCM (1 mL) was stirred over fresh flame-dried 3 Å molecular
sieves under nitrogen. The solution was cooled to −78 °C, after which
TfOH (44 μL) was added. After 30 min, the reaction was stirred at
−10 °C until TLC analysis showed complete conversion of the
acceptor (48 h). The reaction was quenched with Et3N, filtered, and
concentrated in vacuo. The product was purified by size exclusion
(DCM:MeOH = 1:1). Compound 29 (500 mg, 91%, α:β = 10:1) was
obtained as a colorless syrup. [α]D
20 +123.0 (c = 1, CHCl3). IR (neat,
cm−1) ν 697, 736, 1039, 1099, 1261, 1319, 1359, 1454, 1734 (CO),
2106 (N3), 2870, 2926.
1H NMR (CDCl3, 400 MHz) δ 7.77−7.69
(m, 3 H, aromatic H), 7.60 (bs, 1 H, aromatic H), 7.44−7.07 (m, 68
H, aromatic H), 5.73 (d, J = 3.6 Hz, 1 H, H-1), 5.71 (d, J = 3.2 Hz, 1
H, H-1), 5.65 (d, J = 3.6 Hz, 1 H, H-1), 5.09 (s, 1 H, PhCH2), 4.96−
4.91 (m, 9 H), 4.77−4.65 (m, 5 H), 4.58−4.48 (m, 4 H), 4.33−3.62
(m, 37 H), 3.52−3.16 (m, 10 H), 3.05 (d, J = 10.0 Hz, 1 H), 2.99 (d,
J = 10.0 Hz, 1 H), 2.36 (t, J = 7.6 Hz, 2H, H-5°), 1.71−1.61 (m, 4 H,
H-2°, H-4°), 1.45−1.37 (m, 2 H, H-3°). 13C-APT (CDCl3, 100
MHz) δ 173.4 (CO), 138.5, 138.4, 138.2, 137.7, 137.7, 137.6,
137.59, 137.57, 137.5, 137.4, 136.1, 135.7, 133.2, 133.0 (aromatic C),
128.6, 128.5, 128.49, 128.48, 128.45, 128.39, 128.36, 128.3, 128.2,
128.1, 128.05, 128.1, 128.0, 127.94, 127.90, 127.86, 127.82, 127.78,
127.77, 127.72, 127.67, 127.6, 127.42, 127.35, 127.3, 127.12, 127.11,
127.03, 127.0, 126.4, 126.0, 125.9 (aromatic CH), 98.8 (C-1), 98.7
(C-1), 98.1 (C-1), 97.9 (C-1), 97.8 (C-1), 97.7 (C-1), 80.9 (C-3),
80.8 (C-3), 80.7 (C-3), 76.9 (C-3), 76.1 (C-3), 75.7 (C-3), 74.9, 74.5,
74.4, 73.5, 73.3 (CH2), 73.3 (C-4), 73.2 (C-4), 73.0 (CH2), 72.83 (C-
4), 72.80 (CH2), 72.7 (C-4), 72.2, 71.9, 71.7 (CH2), 70.6 (C-5), 70.5
(C-5), 70.1 (C-5), 69.9 (C-5), 69.8 (C-5), 69.6 (C-5), 69.2, 68.3,
68.1, 67.9, 66.8, 66.5, 66.1 (CH2), 64.7 (2 C-2), 63.7 (C-2), 59.5 (C-
2), 59.47 (C-2), 59.4 (C-2), 34.2 (C-5°), 29.1 (C-2°), 2575 (C-3°),
24.7 (C-4°).
Synthesis of Hexasaccharide 30. Compound 29 (20 mg, 0.0078
mmol) was dissolved in THF/H2O/tert-BuOH (2 mL/2 mL/1 mL)
before a catalytic amount of Pd(OH)2/C was added. The reaction
mixture was stirred for 3 days under a H2 atmosphere, filtered, and
concentrated in vacuo. A white powder 30 (6.7 mg, 76%) was
obtained after purification by gel filtration (HW-40, 0.15 M NH4OAc
in H2O).
1H NMR (D2O, 500 MHz) δ 5.40−5.35 (m, 3 H, 3 H-1),
4.85−4.81 (m, 3 H, 3 H-1), 4.13−4.06 (m, 2 H), 3.97−3.50 (m, 35
H), 3.41−3.37 (m, 1 H), 3.15−3.08 (m, 2 H), 2.81 (dd, 2 H), 2.72−
2.70 (m, 2 H), 2.06 (t, 2 H), 1.55−1.43 (m, 5 H), 1.29−1.23 (m, 2
H). 13C-APT (CDCl3, 125 MHz) δ 99.6 (C-1), 99.5 (C-1), 99.5 (C-
1), 99.2 (2 C-1), 97.4 (C-1), 76.9, 76.7, 76.6, 76.7, 73.7, 73.3, 72.4,
72.3, 71.9, 71.1, 71.0, 70.5, 69.2, 68.8, 68.4, 68.3, 61.2, 60.6, 60.4,
55.3, 55.3, 54.6, 51.1, 51.1, 51.0, 37.5, 28.3, 25.7, 25.4. HRMS (ESI)
m/z: [M + 2H]+/2 Calculated for C42H80N6O27: 550.25302; found:
550.25247.
Synthesis of Hexasaccharide 31. Compound 30 (5 mg) was
dissolved in H2O. Then, Ac2O and NaHCO3 were added in the
solution. The reaction mixture was stirred for 3 days until TLC
analysis showed complete conversion of the starting materials. The
product was purified by gel filtration (HW-40, 0.15 M NH4OAc in
H2O). Compound 31 (5.5 mg, 86%) was obtained as a white solid.
1H NMR (D2O, 500 MHz) δ 5.36−5.34 (m, 4 H, 4 H-1), 5.27 (d, J =
4.0 Hz, 1 H, H-1), 4.79 (bt, 2 H, 2 H-1), 4.73 (d, J = 3.0 Hz, 1 H, H-
1), 4.21−4.06 (m, 5 H), 3.97−3.57 (m, 37 H), 3.40−3.35 (m, 1 H),
2.24 (bt, 2 H), 1.97−1.91 (m, 18 H, 6 CH3), 1.80−1.74 (m, 2 H),
1.54−1.46 (m, 4 H), 1.32−1.26 (m, 2 H). 13C-APT (CDCl3, 125
MHz) δ 180.2, 174.7, 174.69, 174.6, 174.5, 174.46 (6 CO), 98.2,
98.15, 96.6 (6 C-1), 77.4, 77.2, 76.1, 75.7, 75.4, 72.5, 72.4, 71.8, 71.7,
71.3, 71.2, 70.7, 70.7, 70.4, 68.5, 68.1, 67.9, 67.6, 66.9, 61.6, 60.7,
60.3, 60.0, 54.4, 54.2, 49.9, 34.6, 28.2, 25.0, 24.4, 22.1 (CH3), 22.0
(CH3), 22.0 (CH3), 21.9 (CH3), 21.9 (2 CH3). HRMS (ESI) m/z:
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Codeé, J. D. C. Mapping the Reactivity and Selectivity of 2-
Azidofucosyl Donors for the Assembly of N-Acetylfucosamine-
Containing Bacterial Oligosaccharides. J. Org. Chem. 2017, 82,
848−868. (b) van der Vorm, S.; Hansen, T.; Overkleeft, H. S.; van
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